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Abstract 
 
The effect of acute and chronic supplementation upon work capacity in trained and untrained 
subjects was examined using 10 normal healthy subjects (ages 19-23). The subjects were tested 
using a double-blind crossover design. During the two supplemental stages subjects ingested 
either the placebo or antioxidant mixture capsules (beta-carotene, vitamin C, vitamin E). There 
was a 28 day washout period between the two supplemental stages. Subjects were tested during 
each stage for an acute effect (one day of supplementation) and chronic effect (twenty-eight days 
of supplementation). Testing consisted of seven sets of arm curl exercises with a 60-second rest 
period between each set. Work, during the last three sets of each phase, was recorded and 
compared for each subject. Hypotheses tested was whether an acute (one day) and chronic (28 
days) supplementation protocol would have an effect upon work capacity in untrained as 
compared to trained subjects. No significant differences were seen after acute or chronic 
supplementation in either trained or untrained subjects. However, power for the study was too 
low to make a determination without a high risk of Type II error. Significant subject dropout and 
work measure variability contributed to the low power.  
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Chapter 1 Introduction / Review of Literature 
The recent interest in antioxidants and free radicals has prompted an increase in the 
supplementation of these substances by many in the general public. Athletes believe that 
supplementing their diet with antioxidants helps to maintain optimum fitness. To this end 
vitamin manufacturers market antioxidants to athletes, professional and amateur alike, as an 
ergogenic aid counteracting the affect of oxidative stress during exercise (Urso and Clarkson, 
2003; Applegate, 1999; Juhn, 2003; American Dietetic Association [ADA], 2000). It is well 
accepted that exercise causes an increase in the production of free radicals and other reactive 
oxygen species (ROS) (Powers and Hamilton, 1999). Among these ROS are O2- (superoxide 
radical), H2O2 (hydrogen peroxide), and OH (hydroxy free radicals). A proliferation of these free 
radicals can cause a decrease in the function of affected cells and can result in a decreased ability 
of muscles to maintain work. Some may believe that the ingestion of antioxidants will help to 
stave off this proliferation of free radicals during exercise and thus provide a beneficial effect.  
Vitamin E, vitamin C, and beta-carotene are three antioxidants that have garnered the 
most attention from those who wish to supplement their diets with exogenous nutrients. Vitamin 
E works to protect cell membranes by breaking the chain reactions that attack the lipid portions 
of those membranes. Vitamin C works in conjunction with vitamin E and is located in the 
cytosol of cells. It helps to regenerate vitamin E that has been used to fight the lipid peroxidation 
occurring within cell membranes. Beta-carotene is a form of vitamin A called pro-vitamin A. It 
can be converted into vitamin A as needed by the body, and much of it is located between the 
lipid bilayers of cell membranes. In this position, it also acts as an antioxidant protecting cell 
membranes. 
During strenuous exercise, there is an increase in oxygen uptake by working muscles. As 
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work intensifies, oxygen uptake increases. This increase in oxygen uptake results in an increase 
in ROS that may result in the fatiguing of working muscles (Powers and Hamilton, 1999). A 
study by Reid and Shoji et al (1992) tested the muscle fibers of rat diaphragm in vitro to 
determine if, while working, these fibers produced an above normal increase in superoxide 
radicals (O2-). Fibers were bathed in a Krebs-Ringer solution containing cytochrome C and 
stimulated artificially (550 mA, 13 V) for one hour. Afterwards, measurements of O2- were taken 
at an absorbance at 550 nm using a spectrophotometer (model 260, Gilford). Repetitive tetanic 
contractions resulted in an increase in absorbance of 400%  relative to relaxed controls, 
indicating an increase in O2- release in active fibers. Addition of superoxide dismutase to the 
medium resulted in an inhibition of this increase in absorbance. This confirmed that O2- was 
responsible for the increase in absorbance. Davies, Quintanilha, Brooks, and Packer (1982) 
exercised rats to exhaustion on a treadmill to observe  the magnitude of increase of free radical 
concentration. The male Long Evans rats were exercised at a sub-maximal work intensity level, 
and immediately sacrificed. Using the electron pragmatic resonance (EPR) spectroscopy method, 
researchers found that there was a two- to three-fold increase in free radical concentration in 
muscle and liver, immediately following exercise.  
The human body has adequate antioxidant defenses under normal physiological 
conditions. These defenses include enzymatic and nonenzymatic antioxidants within the interior 
and exterior of cells. The non-enzymatic include antioxidant vitamins, uric acid, glutathione, 
alpha lipoic acid, bilirubin, and ubiquinones (Powers and Hamilton, 1999). Enzymatic 
antioxidants are located mainly within the mitochondria and cytosol, and include superoxide 
dismutase, glutathione peroxidase, and catalase. The functions of each of these antioxidant 
molecules are illustrated in tables 1.1 and 1.2. It also appears that the body can make adaptations 
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in enzymatic antioxidants depending upon the oxidative capacity of muscle tissue. Jenkins, 
Friedland, and Howald (1984) have shown in the past that, superoxide dismutase and catalase 
show a linear relationship with respect to VO2 max. In a study in which 12 healthy subjects had 
their VO2 max as well as, superoxide dismutase, and catalase activity measured (in the vastus 
lateralis), it was discovered that those subjects with a high aerobic capacity (defined as VO2 max 
over 60 ml/kg/min) had significantly higher levels of both antioxidants, than the subjects with 
lower VO2 max. This suggests that the human body will adapt to a change or difference in 
oxygen consumption and the possibility of a higher than normal influx of ROS in to muscle 
tissue. 
In another study by Robertson, Maughan, Duthie, and Morrice (1991), blood antioxidants 
were measured in six untrained and 12 trained subjects (runners). Twelve runners were assigned 
into two sub-groups - a high mileage group (80 - 147 km/week) and low mileage group (16 - 43 
km/week). Results showed that plasma creatine kinase activity was significantly correlated with 
weekly training distance, indicating that there was muscle damage. The erythrocyte activity of 
glutathione peroxidase and catalase was significantly and positively correlated with the runners 
weekly mileage. This suggests that endurance training may increase blood antioxidant defenses. 
During times when ROS is above normal, such as during prolonged exercise, or when 
antioxidant defense is hampered by nutritional deficiencies, the increase in free radicals may 
cause cell damage (Ji, 1994), decrease endurance capacity by as much as 40% (Davies, 
Quintanilha, Brooks, and Packer 1982), or attenuate force production by as much as 20% (Reid 
and Haack et al, 1992). Because of the recent emphasis on antioxidants in the diet, and their 
connection with optimum health, many individuals have increased their intake of these 
molecules through daily supplementation of multivitamins. Chief among the ingredients of most 
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multivitamins are the antioxidant vitamins E, C, and beta-carotene.  
Function and Role of Beta Carotene 
Beta-carotene is a pre-cursor vitamin A referred to as pro-vitamin A. That is, the human 
body can convert beta-carotene to vitamin A as needed. It is essentially composed of two 
molecules of vitamin A joined together (Guthrie and Picciano, 1995). It also belongs to a class   
Table 1.1 Functions of Enzymatic Antioxidant Molecules 
Enzymatic Antioxidants Functions 
Superoxide dismutase Catalyzes the conversion of two superoxide 
radicals (O2-) into hydrogen peroxide and 
molecular oxygen 
Glutathione Peroxidase Eliminates hydrogen peroxide and organic 
hydroperoxides 
Catalase Eliminates hydrogen peroxide 
 
Table 1.2. Functions of Nonenzymatic Antioxidant Molecules 
Non Enzymatic Antioxidants Functions 
Vitamin E Protects cell membranes from oxidation 
Vitamin C Radical scavenger and regenerates vitamin E 
Uric Acid Scavenges hydroxyl radicals 
Glutathione Serves multiple roles in the cellular 
antioxidant defense 
Alpha Lipoic Acid Effective as an antioxidant and in the 
recycling of vitamin C 
Carotenoids (including Beta Carotene) Lipid soluble antioxidants located primarily 
between lipid bilayers of cells 
Bilirubin May serve as an extra cellular antioxidant 
Ubiquinones Efficient antioxidants in its reduced form 
The data in these tables was taken from Powers and Hamilton (1999) 
 
compounds known as carotenoids, which are pigments synthesized within a number of plants. 
Carotenoids are found in abundance in fruits and vegetables and dairy fats. 
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The term vitamin A is used to refer to the chemical name of retinol. In the small intestine, 
beta-carotene is converted to retinal, which is subsequently converted to retinol. This conversion 
and subsequent absorption takes place in the mucosal cell (Groff et al, 1995) and is dependent 
upon the vitamin A status of the individual and vitamin A content of any given meal (Blomstrand 
and Werner, 1967).  Carotenoids and retinols released from consumed  foods are packaged into 
micelles and subsequently cross the brush border of the small intestine to enter the mucosal cells. 
Within the mucosal cells, retinol is converted to retinyl esters and incorporated into the 
chylomicrons for transport via the lymphatic system, to the liver. Beta-carotene can be converted 
to retinal, which is converted to retinol and subsequently converted to retinyl esters to follow the 
same fate as absorbed retinol. However, some beta-carotene is not converted to retinal and is 
incorporated into the chylomicrons and distributed throughout the lipids of body tissues, mainly 
adipose tissue and the adrenal glands (Guthrie and Picciano, 1995). 
Beta-carotene is located in between the lipid bilayers of tissue cells. It lies parallel with 
the membrane surface deep within the hydrophobic core of the two layers (van de Ven et al, 
1984). It is a lipid soluble antioxidant that aids in the reduction of lipid peroxidation within cells 
(Powers and Lennon, 1999).  Beta-carotene has the ability to quench some free radical reactions 
within membrane systems. This process entails the inactivation of electronically excited 
molecules such as singlet oxygen (O2), generated from lipid peroxidation of cell membranes. In 
singlet oxygen, the peripheral electron is excited to an orbital above that which it usually 
occupies. Singlet oxygen can damage cells unless removed by antioxidants. Beta-carotene can 
also react with peroxyl radicals that are involved in the oxidation of lipids, (Mascio, Murphy, and 
Sies, 1991) thus contributing to the defense of tissue cells. This ability to quench free radicals 
and other ROS can be attributed to the conjugated double bonds within the chemical structure of 
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carotenoids. Beta-carotene reacts with singlet oxygen by transferring excitation energy from the 
oxygen so that it may return to its ground state, without any chemical change to the beta-
carotene. 
Recommended Dietary Allowances and Toxicity 
The Food and Nutrition Board of the National Academy of Sciences sets the  
recommended dietary allowances (RDA) for selected vitamins and minerals. The RDA for 
vitamin A is currently 2300 (women) - 3000 (men) IU. On most commercial labels, vitamin A is 
measured in international units (IU). One IU is equal to 0.3 ug retinol and 3.6 ug beta-carotene, 
or 0.3 retinol activity equivalents (RAE). Currently there is no RDA for beta-carotene or any of 
the other vitamin A precursors. It is not uncommon to see levels as high as 25,000 IU of vitamin 
A in the form of beta-carotene, in commercial vitamin supplements or mixtures. Intakes as high 
as 180 mg (Groff et al, 1995) appear to pose no harmful side effects. This is due in part by the 
body’s selective absorption of beta-carotene as discussed earlier. As consumption of beta-
carotene increases, the percentage of absorption decreases. A condition known as 
carotenodermia may occur. This causes a yellowing of the skin, especially on the soles of the feet 
and palms of the hands. However, this condition is harmless, and disappears following removal 
of the carotenoids from the diet. 
Beta-Carotene Supplementation and Exercise 
 Most research concerning antioxidants with exercise, have investigated how these 
compounds may improve human performance. However, to date there is very little research 
examining the effects of beta-carotene on muscular fatigue or endurance. 
 One study has shown differences, following supplementation with beta- carotene. 
LeBlanc (1998) conducted a study in which trained runners ran a 5K race at maximum effort. 
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The subjects were assigned to two groups. One group received a placebo, and the other 15 mg of 
beta-carotene per day for a period of one month. At the end of this period, 5K race time was 
examined again. Afterward, subjects underwent a washout period of 2 months. Following this 
washout period the groups were crossed over, and the group that had received the placebo 
received the beta-carotene and vice versa, for one month. Following beta-carotene 
supplementation, five kilometer race times showed an improvement from 19.91 minutes (while 
taking the placebo), to 19.36 minutes. This improvement was found to be statistically significant 
with a p value of 0.004. There was no clear cause for the increase in exercise performance, and 
the study concludes that there was not a clear understanding of the mechanism for this 
improvement. However, what is seen in this particular experiment may be a result of an 
increased ability to resist fatigue rather than an improvement in muscular performance per se. In 
endurance races a decrease in race time may be the result of a decreased rate of fatigue, rather 
than an increase in speed or strength. 
Function and Role of Vitamin E 
There are eight compounds produced by plants that could be classified as vitamin E. 
These compounds fall into two classes: 1) the tocols; 2) and the tocotrienols. The most 
biologically active are the four tocols or tocopherols. They are alpha-, beta-, gamma-, and delta-
tocopherol. The most biologically active of those four is alpha tocopherol (Farrel and Roberts, 
1994). Vitamin E content in food or tissue is measured in terms of tocopherol equivalents (TEs). 
One TE corresponds to 1 mg of alpha-tocopherol, and is equal to one IU of alpha tocopherol. 
Vitamin E is distributed in a wide range of foods. Vegetable oils, green leafy plants, and 
the bran and germ of some plants represent the majority of dietary vitamin E sources. Vegetable 
oils have the highest content of vitamin E per gram. However, the average serving of these in the 
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diet is relatively small. The next highest food sources are fortified cereals followed by vegetables  
(Guthrie and Picciano, 1995). 
Absorption of vitamin E occurs in the jejunum via passive diffusion (Erdman et al, 1988; 
Sokol, 1988). The vitamin is carried via micelles into the enterocytes. Similar to other fat soluble 
vitamins, absorption of vitamin E improves when lipids are present in the diet (Bender, 1992). 
Similar to beta-carotene, as vitamin E intake increases absorption decreases. Absorption rate can 
vary between 20 to 50% (Groff et al, 1995) but, in special conditions may rise as high as 80%. 
The supplemental use of vitamin E in doses as high as 200 mg, may result in a drop in absorption  
to 10% (Farrel and Roberts, 1994). 
Once vitamin E enters the enterocyte, it is incorporated into chylomicrons and 
transported via the lymph. While in the lymph, vitamin E equilibrates with plasma lipoproteins, 
(high density lipoproteins [HDLs], low density lipoproteins [LDLs]) and with erythrocytes (red 
blood cells). In the erythrocytes, vitamin E is incorporated into the cell membrane. 
Vitamin E (tocopherol) is distributed throughout the body primarily by the LDLs (Groff 
et al, 1995). Uptake of vitamin E by tissue cells happens mainly in two ways: 1) uptake of LDLs 
by LDL receptors (Traber and Kayden, 1984; Sokol, 1988); 2) or lipoprotein lipase hydrolysis of 
the chylomicrons and very low density lipoproteins (VLDLs) (Groff et al, 1995). Once inside the 
cell it binds to tocopherol binding proteins for transport to cell, mitochondrial, and microsomal 
membranes (Farrel and Roberts, 1994). Vitamin E is distributed throughout the body tissues. 
Most is stored in the adipose tissue with smaller amounts in the liver, lungs, heart, muscles, 
adrenal glands and the brain. The amount of vitamin E in the adipose tissue increases as intake 
increases. However, levels in the other tissues stays constant or increase at a very slow rate. 
When intake is low, withdrawal from the liver and plasma is fairly rapid but, occurs slowly from 
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the adipose tissue (Diplock, 1984). Depletion of vitamin E from the muscle occurs at an 
intermediate rate. 
The main function of vitamin E in the human body is as an antioxidant. It is the body’s 
first line of defense against cellular membrane lipid peroxidation. In tissue cells, vitamin E is 
embedded within the lipid bilayers. There, it can assert its ability to stabilize cell membranes and 
break the chain reactions caused by free radicals and other ROS (Powers and Hamilton, 1999). 
The reduction of molecular oxygen in tissue cells can generate a superoxide radical (O2-) and 
later hydrogen peroxide (H2O2). These can lead to the formation of lipid peroxyl radicals (LOO). 
Lipid peroxyl radicals can remove a hydrogen atom from polyunsaturated fatty acids (PUFA). If 
these PUFA are located within the membrane of tissue cells, it can cause a chain reaction 
throughout the cell membrane. These chain reactions must be broken to keep minimal the 
amount of damage to cell membranes. Vitamin E can break these chain reactions by reacting 
with lipid peroxyl radicals, thus preventing their abstraction of hydrogen in PUFA (Groff et al, 
1995). This is done by providing hydrogen for the reduction of the lipid peroxy radical. 
Furthermore, clinical tests suggest that it (vitamin E) may actually reduce the susceptibility of 
low-density lipoproteins to oxidation by free radicals (Jialal and Grundy, 1992). Once vitamin E 
has broken this reaction it is oxidized to create an alpha tocopheroxyl radical and must be 
regenerated. This regeneration is carried out by ascorbate (vitamin C) via a series of interactions 
between NADPH, and reduced glutathione (Packer et al, 1979; Groff et al, 1995; Wefers and 
Sies, 1988). This relationship is further illustrated in a study by Brown, Morrice, and Duthie 
(1997). They studied the results of a vitamin E supplementation protocol upon oxidative stress in 
smokers and non-smokers. Smokers because of their habit, are in a perpetual state of oxidative 
stress. Smoking brings into the body a higher than normal amount of ROS with which the 
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antioxidant defenses must deal. In this study, fifty smokers had habitually lower plasma 
ascorbate concentrations (p<0.02) and higher susceptibility to hydrogen peroxide (H2O2) 
stimulated erythrocyte peroxidation (p<0.001) than did nonsmokers. They found that after 20 
weeks of supplementation with either 70, 140, 560, 1050 mg alpha tocopherol/day, there was a 
significant decrease in erythrocyte susceptibility to oxidation (p<0.001) in the group of smokers. 
Moreover, there was a decline in plasma ascorbate concentration (p<0.02) in the nonsmokers 
after prolonged alpha tocopherol supplementation. This may be an illustration of the relationship 
between vitamin E and vitamin C discussed previously. 
Recommended Dietary Allowances and Toxicity 
The daily requirement for vitamin E increases as the intake of PUFA increases. On the 
other hand, most foods high in PUFA are also high in vitamin E (Lehman et al, 1986). The RDA 
for women and men is, 8 mg TE/day and 10 mg TE/day respectively. The normal intake of 
vitamin E in American diets ranges from 4 to 22 mg TE/day in adults, who are not 
supplementing their diet with exogenous vitamin E (Di Mascio et al, 1991). Depending upon the 
intake of PUFA in the diet the actual need for vitamin E can range from 5 to 20 mg TE/day 
(Guthrie and Picciano, 1995). The RDA for vitamin E is high enough to maintain a blood level 
of around 0.5 mg/dl, which is considered safe. Deficiency in humans is extremely rare (Groff et 
al, 1995). Usually individuals exhibiting deficiency in vitamin E are low birth weight infants, 
individuals with malabsorption syndromes, and those suffering from abetalipoproteinemia. 
Abetalipoproteinemia is a genetic disease in which apolipoprotein B, necessary for the formation 
of chylomicrons, LDLs, and VLDLs, is lacking (Sokol, 1988). In addition, any disorder that 
affects the absorption of fat will have an affect on the absorption of vitamin E. In the rare 
instance of vitamin E deficiency, anemia can occur because of the hemolysis of red blood cells, 
 11
as well as retinopathy, muscle weakness, and neurologic problems. 
It appears that large doses of vitamin E may be consumed without harmful side effects. 
Intakes between 400 and 800 mg TE/day have been taken for months or even years without any 
harm (Council on Scientific Affairs, 1987).  High dosages of vitamin E may interfere with the 
functions of other fat soluble vitamins (vitamin K, beta-carotene) but, this is only seen in dosages 
exceeding 1 g/day (Groff et al, 1995) 
Vitamin E Supplementation and Exercise 
A relationship between vitamin E and athletic training was first posed in the 1950s 
(Cureton 1954). Cureton suggested that ingestion of wheat germ oil would enhance the rate of 
improvement seen in physical performance following aerobic training in human subjects. At that 
time, it was thought that vitamin E was the active agent within wheat germ oil. Since that time, 
most research investigating vitamin E and exercise performance has involved animals and not 
humans. In 1990 Novelli, Bracciotti, and Falsini (1990) saw a 50% increase in endurance time in 
rats during exercise, following treatment with vitamin E. Swiss mice were injected 
intraperitoneally with a solution of alpha tocopherol in olive oil (100mg / kg body weight), a 
solution of three spin trappers (N-tert-butyl-alpha-phenyl nitrone [PBN], 5-5-dimethyl-1-
pirrolyn-N-oxide [DMPO], and alpha-4-pyridyl-1-oxide-N-tert-butyl-nitrone [POBN]) in saline 
solution, or saline solution alone. Spin trappers are compounds that react with free radicals and 
make them less reactive. Rats were exercised to exhaustion, four at a time, before and after 
treatment by attaching 1 gram weights to their tails and allowing them to swim in a bath until 
exhausted (exhaustion was defined as when a rat’s head submersed three times). Average time to 
exhaustion for the alpha tocopherol treated mice went from 276 seconds to 415 seconds. Time to 
exhaustion for the spin trapper treated mice also increased significantly: 1) PBN treated mice 
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increased from 298 to 393 seconds; 2) POBN increased to 493 seconds; 3) DMPO increased to 
555 seconds. The researchers believe the results of their study indicate that the trapping and / or 
inactivation of free radicals may increase endurance during exercise.  
In an interesting study by Sacheck, Decker, and Clarkson (2000) the connection between 
vitamin E intake and moderate intensity exercise was examined. They recruited 24 female rowers 
from a local college rowing team. After completing a 3-day food diary within one week of the 
exercise test vitamin E intake was assessed. The rowers were assigned to two groups of 12 
subjects. One group was a low fat intake group and the other was a high fat intake group. The 
low-fat group was classified as those ingesting less than 40 grams of fat/day, and the high-fat 
subjects ingested more than 60 grams of fat/day. None of the subjects were supplementing with 
any nutritional substances, taking medications, using oral contraceptives, or consuming alcohol 
during the study time period. Following diary assessment it was discovered that the low-fat 
group was consuming 2.9 mg vitamin E/day and the high fat group 9.8 mg vitamin E/day. The 
low fat group was consuming less than the normal intake range for vitamin E in American diets 
(Di Mascio et al, 1991). However, they were also ingesting a very low fat diet which 
consequently is low in PUFA. The ratio of vitamin E to PUFA (0.56 mg/g) was well above the 
recommended ratio of 0.4 mg/g (National Research Council, 1989) for the low fat group. The 
ratio for the high fat group was 0.69 mg/g. Subjects were instructed to run on a treadmill for 5 
min at a 0% grade, thereafter they ran at a speed that elicited a rise to 75% of their age related 
maximum heart rate (220-age), at a  -10% grade (downhill) for 45 minutes. Venous blood was 
collected immediately prior to exercise, immediately post exercise, and at 6, 24, and 48 hours 
after exercise. Serum vitamin E levels were not significantly different between the two groups 
pre- or post-exercise, nor were there any significant differences seen between low-fat and high-
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fat groups in regards to creatine kinase, malondialdehyde (an indicator of lipid peroxidation), or 
conjugated dienes (formed during the peroxidation of PUFA) pre- or  post-exercise. There were 
significant increases in plasma creatine kinase at 6, 24, and 48 hours post exercise in both 
groups, when compared to pre-exercise values, but as previously expressed there were no 
significant differences between the two groups (no significant interaction). They concluded that, 
although the low fat group did not consume as much vitamin E as the high fat group, and they 
were below the RDA for vitamin E, the intake of vitamin E was sufficient to help protect against 
the oxidative damage brought about by the moderate-intensity exercise. Furthermore, since their 
serum vitamin E levels were normal throughout the study, perhaps the body may be able to 
compensate for low vitamin E intake in the low-fat subjects. It also may be possible that the ratio 
of vitamin E to PUFA plays an important part as well. Although the intake of vitamin E was low, 
the ratio was within the normal values. It is well established that the need for vitamin E increases 
as PUFA intake rises. However, if these low fat individuals were consuming a lower than normal 
amount of PUFA, then the amount of vitamin E they were ingesting may have been sufficient. 
Another question that remains to be answered. Does the training status of these rowers have 
more of an influence upon their ability to stave off the effects of oxidation during moderate-
intensity exercise than their vitamin E status? Being endurance athletes one would expect there 
to be a larger than normal production of enzymatic antioxidants because of training (Roberson et 
al, 1991). It remains to be seen how athletes or untrained individuals would respond to a bout of 
high-intensity exercise, in respect to vitamin E status. 
Although some animal studies may indicate that supplementation with vitamin E may 
decrease exercise induced oxidative stress, in humans most research to date has not indicated any 
improvement in endurance.  Sumida, Tanaka, Kitao, and Nakadomo (1988) supplemented 
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twenty-one healthy male college volunteers with 300 mg vitamin E for four weeks. The subjects 
performed a pre- supplementation and post-supplementation protocol of exercising to exhaustion 
using an incremental exercise test upon a Monark cycle-ergometer. The exercise test involved 
subjects pedaling a Monark bicycle-ergometer at an initial work rate of 4 minutes at zero watts. 
Thereafter, the work rate was increased by 15 watts every minute until a pedaling rate of 60 rpm 
could no longer be maintained. Following data collection, the investigators found no significant 
difference in VO2 peak (Control - 48.9 ml/kg/min; Vit E -  49.1 ml/kg/min) or time to exhaustion 
(Control - 19.0 min; Vit E - 19.1 min). However, this was not a double-blind placebo controlled 
trial. Lawrence et al (1975) supplemented groups of trained swimmers with 900 IU of alpha 
tocopherol or placebo in a double-blind protocol for 6 months, but also found no difference 
between the supplemented and placebo groups. Subjects were given 21 tablets of 300 IU of alpha 
tocopherol or a placebo, every week. They were asked to perform an endurance swimming test 
consisting of 10 laps of 100 yards with a 10 second rest in between. After one month of 
supplementation, the two groups decreased their swimming time by an average of 3%. After six 
months, those in the alpha tocopherol group had decreased their time by 6.8%, and the placebo 
group had increased theirs by 6.2%. These differences however, were not found to be statistically 
significant. This suggests the possibility that a crossover design, in which subjects are their own 
control, might be helpful in detecting differences that may have been overlooked.  Though there 
is much research still to be done, it remains possible that vitamin E may need to be taken in 
conjunction with other antioxidants (Balakrishnan and Anuradha, 1998; Powers and Hamilton, 
1999; Schroder et al, 2000; LeBlanc 1998),  to have an effect upon muscular endurance and / or 
fatigue, and not just in the reduction of free radicals. It may be possible that these combinations 
will have an effect upon the ability to sustain a given amount of work over time 
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Researchers have used many different protocols and subjects to investigate the effect that 
vitamin E would have upon muscular fatigue. Of the studies previously cited none used the 
double blind-placebo controlled design that is most preferred. One injected each of three groups 
with a compound (either spin trappers, alpha tocopherol, or saline solution) to examine their 
effects (Novelli et al, 1990) however, this was not a double blind procedure. Nor was the study 
by Sumida et al (1988), in which they investigated the differences in VO2 and exhaustion, a 
double blind study. Lawrence et al (1975) did use the double blind design in their investigation. 
However, they chose not to employ a crossover within their study. There have also been a 
number of different dosages and methods for ingesting the supplement. Some researchers 
injected subjects with alpha-tocopherol and some had subjects ingest it in tablet form. Thus, 
there is no standard dosage that is used to determine the effect of vitamin E upon work or 
fatigue. Interestingly, Sacheck et al (2000) chose to monitor vitamin E intake levels rather than 
have subjects supplement with exogenous vitamin E. However, no differences were seen in those 
ingesting a high fat or low fat diet. With that in mind, training status may result in a lack of any 
effect of the two diets in that particular investigation. This may also have been the reason no 
significant effect was seen with Lawrence et al (1975) as well. 
Function and Role of Vitamin C 
Vitamin C is probably the most supplemented and researched vitamin known to man. The 
chemical name for vitamin C is ascorbic acid or ascorbate. At one point in history, it was known 
as antiscorbutic because of its ability to prevent scurvy (Guthrie and Picciano, 1995). Human 
beings are one of the few mammals that cannot synthesize ascorbic acid. So therefore, they must 
obtain their supplies of this vitamin through food sources. 
The best sources of ascorbic acid are found in foods of plant origin. Foods such as 
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oranges, cantaloupe, broccoli, green peppers, grapefruit, lemons, and strawberries are among the 
highest in vitamin C content. When any of these foods are cooked or processed using heat, they 
can reduce the amount of vitamin C content. Most plants containing vitamin C are best 
consumed raw to avoid any loss in the content of the vitamin. 
Ascorbic acid has many functions within the human body. It is a water soluble vitamin 
vital in carnitine synthesis (needed for the transport of fatty acids into the mitochondria), 
collagen formation, neurotransmitter synthesis, and most importantly, as an antioxidant. It also 
plays a part in the process to convert cholesterol to bile acids and aids iron absorption (Guthrie 
and Picciano, 1995). 
After ingestion, absorption of vitamin C occurs in the jejunum (Groff et al, 1995). 
Absorption takes place primarily via active transport into the intestinal cells. Before being 
absorbed, it is possible that some ascorbate will be oxidized to form dehydroascorbate because of 
the presence of Fe+++ present in the intestine (Englard and Seifter, 1986; Guthrie and Picciano, 
1995). Dehydroascorbate can be absorbed by passive diffusion into the cells. Once inside the cell 
dehydroascorbate is reduced back to ascorbic acid by dehydroascorbate reductase. Ascorbate 
moves across the basolateral membrane of the intestinal cells by sodium-independent carrier-
mediated transport (Groff et al, 1995). After moving through the cells, ascorbate moves into the 
blood stream and is carried by the plasma throughout the body. It moves with ease into body 
cells. Some tissues have a greater concentration than others. The highest concentration is found 
in the adrenal and pituitary gland (50 times the concentration in serum). More intermediate levels 
are found in the liver, pancreas, lungs, and kidneys (5 to 30 times the concentration in serum). 
Lower levels are found in the muscles, and red blood cells. When amounts up to 100 mg are 
consumed, 80-90% of all vitamin C is absorbed (Guthrie and Picciano, 1995). However, as the 
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amount of vitamin C ingested increases, absorption decreases. As little as 16% is absorbed when 
amounts around 12 grams are consumed. 
The amount of vitamin C within the entire body can be between 1.2 to 2.0 grams when 
100 mg/day of the vitamin are ingested. This is the level deemed necessary to protect the body 
from scurvy for 90 days (Guthrie and Picciano, 1995). If large amounts of vitamin C are 
consumed the body will only absorb and retain enough to maintain a plasma concentration of 1.2 
to 1.5 mg/100 ml. Anything beyond that needed to maintain these levels is excreted. 
As an antioxidant, ascorbic acid may react with OH (hydroxyl radical), O2- (superoxide 
radical), H2O2 (hydrogen peroxide), and HO2 (hydroperoxyl radical). Once ascorbate reacts with 
these ROS, semidehydroascorbate radical (also called ascorbyl) and water, are formed. Two 
ascorbyls react to form ascorbate and dehydroascorbate (Groff et al, 1995). Dehydroascorbate 
can react with glutathione to form ascorbate. As a reductant, vitamin C can reduce cupric (Cu2+) 
to cuprous (Cu+) ions, and ferric (Fe3+) to ferrous (Fe2+) ions (which aids in their absorption in 
the small intestine). These two products (Cu+, Fe2+) may react with free radicals and other ROS, 
and may cause damage to cells via the generation of more ROS (Groff et al, 1995).  Ascorbate 
can react in aqueous environments within the body, including blood, extracellular fluid, and cell 
interiors, before any oxidative damage may occur to lipids (Frei, 1991).  
Recommended Dietary Allowance and Toxicity 
The RDA for vitamin C is currently set at 60 mg/day for adult men and women. This is 
the amount deemed necessary to ensure that body tissues are saturated with the vitamin (a body 
pool of 1500 mg). Some nutritionists believe that the RDA should not be greater than the amount 
needed to prevent scurvy (10 to 12 mg/day) (Guthrie and Picciano, 1995). Conversely, there is 
some evidence that saturation of the tissues of young men with ascorbic acid may require an 
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intake of 138 mg/day (Jacob et al, 1987). 
Vitamin C is relatively non toxic (Alhadeff et al, 1984). However, toxicity is more likely 
when large doses (in excess of 1 gram) are ingested several times a day. This is because 
absorption of vitamin C in the small intestine is saturable and dose dependent (Groff et al, 1995). 
This results in a more pronounced absorption of vitamin C throughout the day as opposed to 
taking one large dose. However, any vitamin C in excess of a body pool between 1200 and 2000 
mg is filtered by the kidneys and excreted in the urine. Finally, unabsorbed vitamin C in the 
intestine can cause diarrhea because of its osmotic effect (Alhadeff et al, 1984), which draws 
water into the intestinal tract.  
Vitamin C Supplementation and Exercise 
For years, athletes have been supplementing with vitamin C with the belief that it will aid 
or at least help to maintain athletic performance. However, much of the research aimed at 
investigating this long held belief has been inconclusive. In one particular animal study, Lang, 
Gohil, and Packer (1986) supplemented guinea pigs with up to 4 grams/ kg of body weight of 
vitamin C for two weeks and observed an increase in endurance capacity. At the same time, they 
did not see a concomitant increase in vitamin C tissue levels, but saw a decrease in muscle 
vitamin E levels. In addition,  ubiquinone levels stayed constant. They suggested that this might 
show a tissue specific interaction between C, E, and ubiquinone. Human studies reveal 
conflicting results. As early as 1966, Spioch, Kobza, and Mazur (1966) injected volunteers with 
500 mg of vitamin C before a 5-minute step test to evaluate the effectiveness of supplementation 
on human performance. They found a reduction in oxygen consumption (by 12%), oxygen debt 
(by 40%), and pulse rate (by 11%). Unfortunately, this study was uncontrolled. Consequently 
there was no way to know if the improvements were attributed to the supplementation or training 
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effect. In 1985 a vitamin C supplemented group of 16 healthy female Indian physical education 
college students, saw improvement in physical efficiency (by 5.0 on the Harvard Step Test), and 
a 9-minute walk / run (236.77 meters)  (Samanta and Biswas, 1985). However, only the 
improvement in 9-minute walk in the supplemented group was significant at p<0.05. Students 
were randomly assigned to an experimental group and a control group. Each subject in the 
experimental group was given a 500mg vitamin C tablet every day for four weeks. 
Unfortunately, they did not compare results against a sedentary group to see differences between 
physically active individuals and the latter. In a study using 286 American Air Force officers, 
half of whom supplemented with 1 gram of vitamin C daily for 12 weeks, a small improvement 
was seen in endurance performance (12-minute run) between supplemented and unsupplemented 
subjects (Gey, Cooper, Bottenberg, 1970). However, this improvement was not statistically 
significant (less than 1%).  Keren and Epstein (1980) saw no improvement in maximum oxygen 
uptake during a cycle-ergometer test, in untrained subjects after they ingested 1 gram of vitamin 
C daily. The untrained subjects were assigned to a supplemented group or a placebo group. Each 
group was given either 1000mg per day of vitamin C or a placebo for 21 days in a double-blind 
manner. Before and after supplementation VO2 max and anaerobic capacity were measured. 
After 21 days of aerobic training (running and hiking), in conjunction with the supplementation 
protocol, no differences were seen (p<0.05) in the aerobic or anaerobic capacities of the two 
groups. 
In 1990, a group attempted to see if a vitamin C restricted diet would have an impact 
upon physical performance in a group of healthy volunteers (van der Beek et al, 1990). Twelve 
healthy subjects were prescribed diets providing low vitamin C intake (20% of the Dutch RDA) 
for seven weeks.  In a double blind manner, six of the subjects were assigned to an experimental 
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group and the other six were assigned to the control group. Both groups also received twice the 
RDA for all other vitamins during the study to ensure no deficiency other than vitamin C. There 
was a 3-week introductory period preceding the 7-week experimental period. The first 2 weeks 
of the introductory period subjects consumed their regular diet and vitamin C equal to the Dutch 
RDA (DRDA) (50 mg/day). At the last week of the introductory period subjects began 
consuming the experimental diet. Once the 7-week experimental period began, the control group 
consumed the prescribed vitamin C deficient diet with twice the DRDA of all vitamins other than 
vitamin K, for the entire supplementation period. The experimental group continued on the diet 
but at weeks 1-3 they also supplemented with twice the DRDA for all vitamins other than C and 
K. At weeks 4-7 they ingested an additional 15 mg vitamin C per day (for a total of 25 mg/day). 
Following this 7-week vitamin C deficient regimen the experimental group received a dose of 
vitamin C per day that was twice as high as the DRDA. Blood was drawn at the before the 
experiment and at weeks 3, 7, and 10. Measures of VO2max and onset of blood lactate (OBLA) 
were measured at the times that blood was drawn. VO2max was determined via an incremental 
cycle-ergometer test. Subjects pedaled at 50 watts at a rate of 60-80 rpm. After 2 minutes work-
rate was increased 50 watts and subsequently 25 watts every 2 minutes thereafter to exhaustion. 
Blood was drawn during the last 30 seconds of each step to determine blood lactate. Following 
data analysis it was found that there were no significant differences between the experimental 
group and the control group for aerobic power or OBLA. There were significant differences 
between the experimental group and the control group with respect to serum vitamin C levels 
(p<0.01). There was a slight increase in heart rate at each of the three exercise tests in the 
experimental group, but this increase was not significant. However, the authors hypothesized that 
this increase may have been related to the lower than normal serum vitamin C level and the 
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effect upon carnitine synthesis and / or catecholamine receptor sensitivity. But no evidence of 
this has been confirmed. Being that subjects were never totally restricted from ingesting vitamin 
C during the course of the study, it may be difficult to ascertain its true effect upon aerobic 
power and OBLA. In this study subjects were supplemented with the DRDA for vitamin C prior 
to the initial restriction period and then for the first three weeks were restricted to 20% of the 
DRDA and then the next four weeks to 50% of the DRDA. Perhaps, for that short period, the 
body was able to maintain a level of serum vitamin C high enough to maintain aerobic capacity, 
by releasing some vitamin C from other tissues throughout the body (i.e. adrenal gland, pituitary 
gland, liver, etc.). 
As with vitamin E, many diverse protocols have been used to test the effectiveness of 
vitamin C on work capacity. Some, like Lang et al (1986), have used animals and, some have 
used human subjects. There have been varying results between species among the studies cited, 
and there does not appear to be a clear-cut answer as to how effective vitamin C may be. Some 
have used trained volunteers (Samanta and Biswas, 1985; Gey et al, 1970;), while others have 
used untrained subjects (Spioch et al, 1966; Keren and Epstein, 1980; van der Beek et al, 1990). 
There has also been a wide variety of experimental designs. Some used no controls, while others 
used a control group. At least two used a double-blind method (Keren and Epstein, 1980; van der 
Beek, 1990) while most did not. In human subjects, the dosages range between 500mg and 
1000mg per day. Most studies examined the chronic effect of vitamin C supplementation upon 
muscular work and / or aerobic capacity, while only one examined the effect of an acute dosage 
of the vitamin. In addition, one study examined the effect of chronic versus acute dosing upon 
human subjects. Allesio et al (1997) supplemented subjects with 1000 milligrams of vitamin C or 
a placebo, per day for 1 day and 2 weeks. At 1 day and at 2 weeks subjects performed 30 minutes 
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of submaximal exercise. Before and immediately following exercise plasma thiobarbituric acid 
and reacting substances (TBARS) and, oxygen radical absorbance capacity (ORAC) were 
measured. TBARS are biomarkers of oxidative damage (LeBlanc, 1998) used to indirectly 
measure the extent of lipid peroxidation in biological systems. They (Alessio et al, 1997) found 
that following the exercise TBARS were 12.6 and 33% above resting values in the supplemented 
group, compared to 46% higher in the placebo group. No changes were seen in ORAC. When 
comparing oxidative stress (represented by the ratio of TBARS to ORAC), the placebo group 
noticed a 32% increase compared to 5.8 and 25.8% in the vitamin C group at 1 day and 2 weeks, 
respectively. This led to the conclusion that oxidative stress was higher in those who ingested the 
placebo, than those who ingested vitamin C. 
None of the aforementioned  investigations were conducted in a double-blind crossover 
design. This design would be the most thorough method of detecting any differences between or 
within an experimental group and, it would be the method of choice for a subsequent study on 
this subject. 
Antioxidant Combinations 
There have been a few groups who have attempted to study the effects of some 
antioxidants in combination and how they may effect muscular work or endurance. Rokitzki et al 
(1994) set out to examine if supplementation with antioxidants could influence lipid peroxidation 
and muscle enzymes. The subjects were 22 trained long distance runners. Half of the subjects 
ingested an antioxidant capsule of 400 IU alpha tocopherol and 200 mg vitamin C per day, while 
the others received a placebo for a total of 4.5 weeks. At the end of the supplementation period 
the subjects participated in a marathon race. Serum measures of retinol, ascorbic acid, beta-
carotene, alpha tocopherol, malondialdehyde, uric acid, glutathione peroxidase, and catalase 
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were taken at 4.5 weeks before, immediately before and after, and 24 hours after the marathon. 
Serum concentrations of alpha tocopherol and ascorbic acid increased significantly after the 4.5 
week supplementation period in the supplemented group. There were no significant changes in 
glutathione peroxidase or catalase. There was a significant increase in creatine kinase 
concentration immediately after and 24 hours after the marathon, in both the supplement group 
and control group. However, the creatine kinase  increase in the supplemented group was 
significantly lower than in the control group. As creatine kinase is an indicator of muscle damage 
it was concluded that the supplementation with the alpha tocopherol / vitamin C combination 
helped to reduce the amount of blood creatine kinase increase during exercise. However, one 
drawback is that there was no way of measuring the intensity at which the subjects ran the race. 
It may be possible that they were running at a much lower pace than usual, which would not 
necessarily be comparative to results after running as fast as they could cover the distance. 
Similar results were found by another group recently (Bryant, Ryder, Martino, Kim, and Craig, 
2003). They used seven trained cyclists in which each ingested two capsules per day containing 
these four treatments: placebo (placebo plus placebo); vitamin E (400 IU per kg plus placebo); 
vitamin C (1 gram plus placebo); and vitamin C and E (1 gram of C and 200 IU per kg vitamin 
E). The treatment order was placebo, vitamin C, vitamin C and E, vitamin E. Each subject 
ingested the treatment in the same order. Each supplementation phase lasted for 3 weeks for a 
total of 12 weeks. At the end of each phase subjects performed a steady state ride on a cycle 
ergometer for one hour followed by a 30-minute performance ride. The steady state ride was at 
70% of VO2 max at a pedal rate of 90 rpm. Immediately afterwards, the performance ride was at 
the same workload, but subjects could establish their own pedal rate. Blood samples were 
collected immediately before and after the exercise trials and analyzed for malondialdehyde and 
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lactic acid. Results showed that malondialdehyde levels pre-exercise (2.94 umol and 4.81 umol) 
as well as post exercise (4.32 umol and 7.89 umol), were lower during the vitamin E phase than 
during the placebo phase. Lactic acid levels were also lower in the vitamin E supplementation 
period than the other three periods, although not statistically significant. They also noted that 
total  work levels decreased after each supplementation phase. Although interesting it would 
appear that because these subjects were training during the study, their training may be having 
more of an effect upon these measures than the actual supplementation regimen. Additionally, 
each supplement was only taken for 3 weeks which may not be enough time to evaluate each 
individually especially considering that the third phase was a combination between C and E. A 
larger study utilizing a crossover design, untrained subjects, and perhaps a washout period would 
give a clearer picture to the effect of either of these antioxidants. However, the authors point out 
that because of time restraints they were unable to perform a washout in this particular study. 
Another group set out to investigate the influence of a vitamin C and E combination upon 
muscular damage using trained athletes similar to an aforementioned study. Dawson et al, (2002) 
had 15 male distance runners divided into two groups. One group supplemented with 500 mg of 
vitamin C and 500 IU of vitamin E, or 1000 mg vitamin C and 1000 IU vitamin E, for 4 weeks. 
The other group received a placebo. Following this first supplementation period subjects ran a 21 
km race as fast as possible. Afterwards, there was a 4-week washout period followed by a 
crossover in the supplementation regimen for each subject.  Following another 4-week 
supplementation period another 21 km race was run. Venous blood was taken before, 
immediately after, and 24 hours after each run. Samples were analyzed for creatine kinase, 
myoglobin, malondialdehyde, and both vitamins. There was also a subgroup that had muscle 
biopsies taken 24 hours before and 24 hours after each run. Both vitamin dosages produced very 
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similar results so, vitamin groups were combined into one group. There were significant within 
group differences (p<0.05) seen in serum creatine kinase, and myoglobin levels, but not 
malondialdehyde, after the run. However there were no between group differences for those 
same measures. In the biopsy samples there were changes seen consistent with endurance 
training but, again no significant differences between the placebo and supplemented conditions. 
They concluded that this dosage of vitamin C and E did not reduce biochemical or muscle 
structural indices for damage in these runners. It appears that it may be possible that these 
runners were so highly trained that they may already have more than enough enzymatic 
protection through adaptation, against the affects of oxidative stress in working muscles. A 21 
km run is an extremely long event and there is no indication of the workload that these 
individuals were using in the study. The authors assumed that the athletes were running as fast as 
possible, but there was no way to measure this. In a long event as this it is quite possible that 
these runners never reached a point at which their already enhanced enzymatic antioxidant 
systems was over stressed. If the authors had required the subjects to run on a treadmill, true 
workload may have been quantified and compared rather than relying on the subjects honest 
effort. 
Pro-oxidant Activity of Beta Carotene, Vitamin E, and Vitamin C 
Beta-carotene, vitamin E, and vitamin C are antioxidants. However, it has been suggested 
that they may also serve as pro-oxidants in certain situations. They may promote oxidation via 
their action upon certain molecules, such as cupric (Cu2+) and ferric (Fe3+) ions, or depending 
upon which nutrient, by the failure to regenerate after serving in their role as an antioxidant. 
There have been some reports of pro-oxidant effects of beta-carotene in vitro when high 
doses have been administered. However, the in vitro pro-oxidant effect of beta-carotene was 
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dose dependent only in an environment of 100% oxygen pressure(Palozza et al, 1995). Palozza et 
al, (1995) used rat liver microsomal membranes exposed to 2,2` -azobis (2-amidinopropane) 
(AAPH), a radical initiator, to illustrate this point. They showed that at a PO2 of 150 mm Hg 
beta-carotene acted as an antioxidant, inhibiting AAPH induced malondialdehyde (MDA) 
formation. However, at 760 mm Hg PO2 beta-carotene lost its antioxidant properties resulting in 
an increase in lipid peroxidation. Their group used four different concentrations of beta-carotene 
to illustrate the point that different dosages would elicit a slightly different effect. At a PO2 of 
150 mm Hg, there was a decrease in MDA at each of four successively higher concentrations of 
beta-carotene. On the other hand, at a PO2 of 760 an opposite effect was seen. At the same four 
successive concentrations of beta-carotene an increase in MDA is seen.  Later they showed that 
the effect was prevented by a concomitant addition of alpha tocopherol, illustrating the 
cooperative interaction of these two antioxidants. Another study showed that beta-carotene acted 
as an antioxidant and inhibited AAPH induced lipid peroxidation in normal and in tumor cells at 
150 mm Hg PO2 (Palozza, P. et al, 1997). However, when PO2 was increased to 760 mm Hg 
beta-carotene exhibited a pro-oxidant effect, in addition to losing its antioxidant effectiveness. It 
was noted that the pro-oxidant activity was more pronounced in the tumor cells than in the 
normal cells.  More study is needed to investigate these effects in vivo. It is possible that beta-
carotene is incorporated into biological membranes in vitro differently than in vivo (Liebler, 
D.C. et al, 1997). PO2 in living tissues is much lower than those in the aforementioned studies. 
Arterial blood PO2 is 100 mm Hg and in most tissues it is 40 mm Hg or less (Vander et al, 1990). 
Therefore, it is likely that any pro-oxidant properties displayed by beta-carotene in vivo would 
not be caused by a high partial pressure of oxygen. 
The pro-oxidant effect of beta-carotene may be caused by the auto-oxidation of beta-
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carotene at higher PO2 values in vitro. It may be possible that at high oxygen  PO2, a chain-
carrying beta-carotene peroxyl radical is formed (Burton, 1989; Burton and Ingold, 1984; 
Kennedy and Liebler, 1991). This may be the reason why antioxidant effectiveness is reduced in 
high PO2 environments (Kennedy and Liebler, 1992). Carotenoids may interact with free radicals 
in three ways: 1) electron transfer; 2) hydrogen abstraction; 3) and radical species addition  
(Young and Gordon, 2001). The products of these reactions may react with oxygen to produce 
peroxyl radicals. In the end, it may not be a pro-oxidant effect that is seen, but a reduced 
antioxidant effect (Palozza et al, 1995). An environment of 100% oxygen is not physiologically 
tangible so, it is not likely that beta-carotene would display a pro-oxidant effect in vivo (Burton 
and Ingold, 1984). However, as there are varying PO2 throughout body tissues, all less than 40 
mm Hg, it is possible that beta-carotene may be more or less effective as an antioxidant 
depending upon the tissue. 
Few reports show any pro-oxidant effects of vitamin E. Most, if not all, have been in 
vitro studies, and most have been in abnormal physiological environments. As discussed 
previously, alpha tocopherol is a major antioxidant present in LDLs (Sokol, 1988). It is assumed 
that increasing the amount of alpha tocopherol in LDLs would make them less susceptible to 
oxidation. However, under mild oxidative conditions it has been shown that increasing 
tocopherol within the LDL may increase LDL susceptibility to oxidation (Bowry et al, 1992). 
The reason for this increase in oxidizability is the action of the alpha tocopheroxyl radical. This 
radical, sustained within the LDL for a sufficient amount of time, will begin to oxidize the 
PUFAs within LDL in vitro (Bowry and Stocker, 1993). Since alpha tocopherol scavenges free 
radicals and other ROS, the more alpha tocopherol present, the increased amount of radicals that 
can or will be scavenged (Witting et al, 1999). During high fluxes of ROS, vitamin E prevents 
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lipid oxidation. However, when there is a low level of ROS, lipid peroxidation may be caused by 
vitamin E, specifically alpha tocopheroxyl radical. Normally, alpha tocopheroxyl radical can also 
participate in the reduction of lipid peroxyl radical into non radical products (Witting et al, 
1999). When lipid peroxyl radical levels are not high, alpha tocopheroxyl radical will begin to 
oxidize PUFAs if there are insufficient co-antioxidants, such as vitamin C, to regenerate alpha 
tocopherol (Bowry et al, 1995). In an experiment by Kontush et al (1996) they showed that, in 
vitro, this pro-oxidant effect is apparent under certain circumstances. In human plasma and LDLs 
alpha-tocopherol developed antioxidant and pro-oxidant activity depending upon oxidative 
conditions and presence of vitamin C. In what was termed a “strong oxidative condition” 
(plasma diluted 150 fold or two fold, with 50 micromoles CU2+ and 25 millimoles of AAPH, 
respectively) alpha-tocopherol displayed antioxidant behavior in both plasma and LDLs 
regardless of the amount of vitamin C in the sample. Under “mild oxidative condition” (plasma 
diluted 150 fold with 0.5 micromoles and 333 micromoles of AAPH respectively) alpha-
tocopherol was shown to have a pro-oxidant effect. However, it was noted that this was only 
seen when the samples were “virtually free” of vitamin C or the amount was much lower than 
physiological levels (Kontush et al, 1996). Once vitamin C was added to these samples 
antioxidant activity of alpha-tocopherol was restored. In the final analysis it was pointed out that 
alpha-tocopherol should always function as an antioxidant, as long as the concentration of other 
co-antioxidants, such as vitamin C is high enough to regenerate alpha-tocopheroxyl radical back 
to alpha tocopherol. Considering vitamin C’s high concentration in human plasma it is highly 
probable, in vivo, vitamin E should act as an antioxidant regardless of the oxidative conditions 
(Kontush et al, 1996). We know that, in vivo, vitamin E indeed usually acts as an antioxidant 
(Groff et al, 1995; Janero, 1991). It appears that only in situations where co-antioxidants, such as 
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vitamin C, are exhausted or, there is an abnormal condition like thalassemia (Olivieri et al, 1994) 
or Wilson’s disease (Ogihara et al, 1995) is there a chance of pro-oxidant activity by vitamin E in 
vivo.  
There are very few studies showing any pro-oxidant effects of vitamin C. Generally, the 
pro-oxidant effect of vitamin C is not seen via its direct action upon other molecules, rather, it is 
with its action upon Cu2+ and / or Fe3+ (Herbert, 1996). As previously stated, after ascorbic acid 
reduction the products, Cu+ and Fe2+, can react with hydrogen peroxide or oxygen to form 
hydroxy radicals or superoxide radicals (Groff et al, 1995). Afterwards these ROS can damage 
membranes by attacking lipids and proteins embedded in the membrane itself. Most reports of 
ascorbic acid and a possible pro-oxidant effect were seen in studies investigating tumor growth 
and cancer (Alcain et al, 1990). In certain populations in which there is the potential for the 
accumulation of iron, such as hemochromatosis or thalassemia, ascorbic acid supplementation 
may cause an accumulation of toxic levels of iron (Schwartz, 1996). In addition, high levels of 
iron provide a large supply of substrate for hydroxyl ion formation, which ultimately can lead to 
lipid peroxidation (Wagner et al, 1993). 
Muscular Fatigue 
Muscular fatigue has been defined as “the failure of a muscle fiber to maintain tension as 
a result of previous contractile activity” (Vander et al, 1990). High muscular forces can be 
maintained for a shorter period than low muscular forces (Lieber 1992), and a direct result of 
muscular fatigue is a decline in the rate of force production. It has been shown that substrate 
depletion can be a major factor in the fatigue of contracting muscle, depending upon the intensity 
of the exercise being performed. In low force, endurance type activities, fatigue may depend on 
the amount of glycogen available. In high force, shorter time interval activities, fatigue may be 
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dependent upon the muscles ability to replenish ATP via ATP-PC system, anaerobic glycolysis, 
and / or oxidative phosphorylation. If muscle ATP demands are not adequately met, then force 
production attenuates over time (Lieber 1992). Also, fatigue  in shorter time, high force activity 
is caused in part by the increase in intracellular acidity brought about by lactic acid buildup 
(Vander et al, 1990). 
In addition to substrate availability, there are numerous other theories for the mechanisms 
involved in fatigue. Among those are disturbances in electrolyte balance and / or changes in 
skeletal muscle oxygen-reduction status (Powers and Lennon 1999). In the study by Novelli et al 
(1990), spin trappers were used to scavenge free radicals in exercising rats. Spin trappers are 
compounds reacting with free radicals, and may even be classified as a free radical scavenger. 
The rats were exercised to exhaustion, and compared to rats that had undergone the same 
protocol, but without receiving the spin trappers. Those that had received the spin trappers had a 
longer time to exhaustion (on average 185.7 seconds longer). Reid, Haack, et al (1992) 
determined that: 1) muscular contraction increases intracellular oxidant levels; and 2) reactive 
oxygen intermediates promote low frequency (fibers stimulated at 30 Hz as opposed to 200 Hz, 
for five minutes) fatigue. Their study involved rat diaphragm bundles mounted in chambers 
containing Krebs-Ringer solution loaded with 2',7'-dichlorofluorescin (a fluorochrome that emits 
at 520 nm when oxidized). Bundles were artificially stimulated to contract repetitively at 30 Hz. 
Increase in ROS were shown during stimulation via the fluorochrome during the period of 
repetitive contractions. 
Measuring fatigue is a very complex notion, as it can be influenced by both physical and 
psychological factors (Astrand and Rodahl, 1986). It is not uncommon to perceive a certain work 
output as being strenuous one day as opposed to the previous day. An example of the 
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psychological influence of fatigue is in track and field. Many times we have seen an athlete 
finish a race in victory, and take a victory lap, all while his competitors are sprawled on the 
track. All of the athletes are fatigued but, for some reason the winner always seems to have the 
energy to celebrate. This is most certainly due to some psychological factor. Factors that may 
possibly play a part in muscular fatigue include central nervous system fatigue, peripheral nerve 
fatigue, and neuromuscular junction fatigue. The control sequence for activation of voluntary 
muscle as posed by Astrand (1986) occurs in this order; Mood - Brain - Spinal Cord - Peripheral 
Nerve - Neuromuscular Junction - Muscle Fiber Membrane - Sarcoplasmic Reticulum - Ca2+ 
Ions - Actin and Myosin Interaction. Central nervous system fatigue is sometimes referred to as 
psychological fatigue (Vander et al, 1990). This is illustrated by a failure of the cerebral cortex to 
send signals to the motor neurons, which can lead to the failure of muscle fibers to contract, even 
though the muscles are not fatigued. In the case of an athlete his performance may depend on his 
“will to win” (or mood / motivation) to overcome this type of fatigue. However, Merton (1954) 
showed that this may not necessarily be the case. In his classic study he had subjects performing 
a number of repeated contractions and as time wore on he would superimpose a large electrical 
stimulation over the voluntary contraction. He hypothesized that if CNS fatigue had any 
influence upon muscular fatigue then the artificial stimulation would increase force produced 
during a voluntary contraction. No force increase was observed in this study so he concluded that 
CNS fatigue was not a factor in muscle fatigue. Bigland-Ritchie, Kakulka, Lippold, and Woods 
(1982) showed that although force may decrease over time within a muscle, they demonstrated 
that there is no change in muscle mass action potential and would suggest that the neuromuscular 
junction is not the weak link in muscular fatigue. Gandevia, Herbert, and Leeper (1998) also 
showed that although there may be development of muscular fatigue as muscular work is 
 32
occurring, the capacity to maintain maximal levels of activation can be maintained. 
Measuring fatigue in a non-invasive fashion has become a lot easier today with the help 
of computerized dynamometers. Researchers have used a number of different protocols to 
measure fatigue, however most have been based upon the premise that as a muscle(s) fatigues, 
force attenuates. The most common measurements used are peak torque, work, and power. For 
example, Svantesson et al (1998) studied fatigue during repeated eccentric and concentric 
contractions of the plantar flexors. Subjects were tested to see if there was a difference in fatigue 
development during concentric actions versus concentric-eccentric actions. A protocol for 
measurement of the concentric was performed and compared against a similar protocol for 
measurement of the eccentric, using plantar flexion as the action tested on the isokinetic 
dynamometer. The test was performed to exhaustion, and the total amount of work was recorded 
at the end of each test. They found that work declined similarly over time in both tests and, that 
when evaluating fatigue during muscular performance, the concentric-eccentric test should be 
used.  
In a study by Pincivero, Gear, Moyna, and Robertson (1999), the effects of rest interval 
on quadriceps torque were tested. The study used two groups of subjects who were each assigned 
a different protocol to perform on a Biodex System II Isokinetic Dynamometer. All the subjects 
performed four sets of twenty maximal isokinetic knee extensions at an angular velocity of 180 
degrees per second. Group one was given a 40 second rest between each set and, group two was 
given a 160 second rest between sets. The results showed that there was a significantly greater 
decline in peak torque (p<0.05), total work (p<0.05), and average power (p<0.05) with group one 
when compared to group two. 
In a unique study by Ellenbecker and Roetert (1999), they attempted to show if there was 
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a difference in the fatigue rate between shoulder external and internal rotation of the dominant 
and non dominant arms, in elite junior tennis players. The protocol consisted of the subjects 
undergoing bilateral isokinetic testing with 90 degrees of glenohumeral joint abduction. They did 
twenty maximal effort concentric contractions of the external and internal rotation, at a speed of 
300 degrees per second. The fatigue was measured by calculating a fatigue ratio. The fatigue 
ratio was calculated by dividing the work in the last 10 repetitions by the work in the first 10 
repetitions. They found significant difference between the fatigue ratios for the external versus 
the internal rotations but, no difference between the dominant and non dominant arms. 
Therefore, it would seem that work is a viable measurement of fatigue rate of muscles while 
investigating the effect of supplementation on fatigue. 
Summary 
As mentioned previously, athletes and fit individuals are constantly under a barrage of 
advertising from vitamin and supplement manufacturers promoting the use of vitamin 
supplements. Many young athletes spend upwards of hundreds of dollars on these supplements 
every month. However, it has been shown that most athletes consume more than enough of the 
RDA for most nutrients (ADA, 2000) in their normal diets - which contains more calories on 
average than the average person. If this is the case, and the manufacturers know this, then the 
constant advice to ingest vitamin supplements is not based upon science but, rather the ignorance 
of the target audience. 
As it has been shown, there are any number of protocols and dosages that have been 
employed in investigating the effectiveness of the antioxidants in question, both alone and in 
combination. However, there is no consistency among the many methods and combinations 
employed. It is accepted that vitamin E is the main chain breaking antioxidant with respect to the 
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protection of the membranes of tissue cells. Although one study has shown an improvement in 
time to exhaustion while supplementing with vitamin E in rats (Novelli et al, 1990), it has not 
shown to be an effective substance to help reduce fatigue by itself (Sacheck et al, 2000; Sumida 
et al, 1989; Lawrence et al, 1975). However, there are some diverse methods used in some 
studies to test the effectiveness of vitamin E. One consistent characteristic in some of the 
investigations is the use of endurance trained subjects (Sacheck et al, 2000; Lawrence et al, 
1975). As mentioned previously, there is an accompanying increase in the enzymatic 
antioxidants in endurance trained subjects (Miller, 1992). It may be possible that their training 
status may supercede any effect of supplementing in these individuals in during submaximal 
exercise. Sumida et al (1989) found no difference with vitamin E supplementation in cycle time 
to exhaustion or VO2 max while using untrained healthy subjects for the investigation. However, 
the study was neither double blind and involved no placebo group, consequently there is no 
guarantee that the results are not biased. 
As stated earlier, vitamin C is probably the most studied vitamin among the three 
antioxidants mentioned. There have been all manner of protocols followed to investigate the 
antioxidant properties of vitamin C and its influence upon muscular work. In the study by Lang 
et al (1986) we see an improvement in endurance capacity in guinea pigs who have been 
supplemented with 4 g/kg of vitamin C. In human subjects, nonetheless, there are mixed results. 
Samanta and Biswas (1985) supplemented 16 healthy adult females with 500 mg vitamin C or 
placebo for 4 weeks. They saw improvement in distance covered (1813.83 meters pre-test, 
2026.75 meters post-test) during a nine minute walk / run in the vitamin C group after the 4 
weeks when compared to before supplementation (p<0.05). The placebo group saw no 
improvement. Gey et al (1970) supplemented 286 male air force officers with 1000 mg vitamin 
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C per day for 12 weeks. Before and after the 12 weeks subjects were tested on a 12 minute walk / 
run test. Afterwards there was a small but insignificant increase in distance covered during the 12 
minute test. But, neither of these investigators chose to compare their groups against sedentary 
subjects to test if there was any training effect. Keren and Epstein (1980) used a double blind 
placebo controlled protocol, but did not see an improvement in aerobic or anaerobic capacity (on 
the cycle ergometer) in either control or placebo group, after three weeks of running and hiking 
training. Ideally the test of aerobic or anaerobic capacity should be in the same activity in which 
participants were training. In an interesting twist van der Beek et al (1990) used vitamin C 
restricted diets to show no negative effects upon aerobic power and onset of blood lactate. 
However, this might have been more informative if they had compared their subjects to trained 
individuals to see if the same effect is seen. Again, we see a variety of different methods to test 
the effectiveness of vitamin C but, no clear cut determination of its influence upon muscular 
work. But, it is clear that more investigation should be done using trained and untrained subjects 
as opposed to one or the other. 
Beta-carotene has not been widely studied in relation to its influence upon muscular 
work. LeBlanc investigated it in connection to its influence upon 5k race times. They 
supplemented with 15 mg beta-carotene or placebo per day for one month. Following a washout 
period the groups were crossed over, and it was determined that there was a significant 
improvement in 5k race times. Since beta-carotene is located between the lipid bilayers of cell 
membranes, it may be more possible that beta-carotene should be taken in combination with 
vitamin C and E. A few studies have looked at combination of vitamin C and E together, but 
without beta-carotene. Dawson et al (2002) used 15 experienced runners and divided them into 
two groups (vitamin or placebo). The vitamin supplement was a combination of 500 mg vitamin 
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C and 500 IU vitamin E, or 1000 mg vitamin C and 1000 IU vitamin E. The runners 
supplemented for 4 weeks then completed a half marathon run. Afterwards a four week washout 
period followed before the subjects were crossed over and received the other capsule for four 
weeks. After that second period another half marathon was run. Following each run blood was 
collected and analyzed for creatine kinase and malondialdehyde. There were significant increases 
seen in creatine kinase (p<0.05) but not malondialdehyde between the vitamin and placebo 
groups. Rokitzki et al (1994) used runners in their study in a similar fashion. Subjects were 
assigned to either a placebo or vitamin (400 IU vitamin E, 200 mg vitamin C) for 4.5 weeks. 
Following supplementation they ran a marathon race. Comparing immediately after the race to 
24 hours post race, there were significant increases in creatine kinase in the supplemented and 
placebo group. However, the increase in creatine kinase in supplemented subjects was 
significantly lower than in the placebo subjects (p<0.01). There were no differences seen in 
malondialdehyde levels between the two groups. However, there was no way to know if subjects 
were giving an all out effort during the run, as there was no way to quantify the actual work 
performed. In the study by Bryant et al (2003) mentioned earlier, the same case can be made. 
Although subjects supplemented with vitamin C and E, considering the supplementation protocol 
there was no way to determine if lower malondialdehyde levels were a product of training or the 
antioxidant combination. 
There is no conclusive evidence supporting the ingestion of antioxidant supplements. 
Much of the advocacy of supplementation with these nutrients is based upon theoretical ideas. In 
table 1.3 we see that there are a number of studies looking at each of the aforementioned 
antioxidants. There is no conclusive evidence from these studies that either of the antioxidants 
can affect muscular work. There are mixed results for each antioxidant and, most did not use two 
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groups of volunteers. They either used trained or untrained subjects but usually not both. In 
addition, only one of these studies investigated subjects’ deficiency status for each nutrient, prior 
to the supplementation protocol. LeBlanc (1998) investigated subject status for beta-carotene and 
discovered that on average, they were on the lower end of the typical beta-carotene intake of 
American adults (Henderson et al, 1989).  
Finally, none of the studies cited have used the mixture of beta-carotene, vitamin C, and 
vitamin E when investigating antioxidant supplementation upon muscular work. Although there 
has been no conclusive evidence to support the supplementation of these nutrients, perhaps the 
combination of these three may have a significant effect considering their interrelationship 
within the cell membrane. 
Main Points 
1. No one has compared the effect of beta-carotene, vitamin E, and vitamin C in 
combination upon muscular fatigue. 
2. No one has compared the effect of beta-carotene, vitamin E, and vitamin C in 
combination after acute and chronic supplementation, while using a double-blind 
crossover experimental design. 
3. Few studies compared trained and untrained subjects 
4. The literature is limited concerning the effect of beta carotene upon fatigue and 
more research is warranted 
5. As Vitamin C helps to regenerate vitamin E within the cell, via its interaction with 
the alpha tocopheroxyl radical, it may be possible that these vitamins may work in 
conjunction to affect muscle fatigue during intermittent work 
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Project Rationale 
Muscular work causes an increase in oxygen consumption and ultimately an increase in 
free radicals and other ROS. This increase in ROS can attenuate muscle work capacity and may 
cause the cessation of work production altogether if their removal is not prompted in a timely 
fashion. Many popular sports involve short bursts of activity followed by a rest period or period 
of reduced activity (basketball, track and field, football, tennis), whether during training or in 
competition. Since these activities involve these short time periods of activity it may be of 
importance to stave off the effects of fatigue, during intermittent time periods of work, than the  
overall endurance capacity. With this being the case, any positive effect that antioxidant 
supplementation may have upon the improvement of work capacity during these times would 
most likely be welcome. Conversely, if the case were that supplementation with these 
antioxidants has a negative effect, surely most athletes would not be encouraged to supplement 
them in their diets. 
Preliminary Studies 
 In a pilot study conducted in our laboratory we instructed the subjects to perform a 
prescribed intermittent work protocol of five sets of 20 arm curl repetitions, with 60 seconds rest. 
The rest period was long enough to allow the aerobic energy system to contribute towards energy 
production (Astrand, 1986, pp. 304-307) and to ensure that subjects could give an “all out” 
effort. Only the last two sets were used to evaluate fatigue. However, supplementation with a 
beta-carotene, Vitamin E, and Vitamin C combination resulted in mixed findings. A two-way 
factorial (mixed model) ANOVA design with repeated measures, was used for analysis. There 
were six untrained and ten trained subjects which resulted in unbalanced groups. However, as 
with most statistical software (Freund, 1997, pp. 486), the SAS software accounted for this 
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difference in the analysis by using the Proc Mixed procedure. Three conditions were compared: 
1) Pre-supplementation; 2) Acute supplementation (one day of supplementation); 3) and 25 days 
of supplementation. At p<0.10, there were significant main effects for subjects’ status (trained or 
untrained) (p=0.10), the interaction of status and supplemental state (p=0.05), and the interaction 
of supplemental state and the day (pre, acute, 25 days) (p=0.09). In  figure 1.2 we see slightly 
lower work, in acute as compared to chronic supplementation in trained subjects. In untrained 
subjects we see (figure 1.3) an increase from pre to acute, and an increase from acute to chronic 
supplementation with regards to work. Although the results seem to be  mixed, it may be that 
chronic supplementation with the antioxidant mixture may have a positive impact upon work in 
the untrained subjects. Unfortunately, subjects dietary status for the antioxidants is not known. It 
may be possible that the untrained were below the safe intake levels of one or more of the 
antioxidants, and that possibly this may affect muscular fatigue during intermittent work  With 
this information it may be more conclusive to conduct a study with a larger number of subjects 
using a crossover design, in which subjects are able to supplement on both placebo and the 
antioxidants. In addition, having knowledge of the subjects average dietary intake for the 
antioxidants would give a more clear picture of their body status for the supplements. 
Problem Statement 
The purpose of this study is to investigate the effect supplementation with an antioxidant 
mixture of beta-carotene, vitamin E, and vitamin C, will have upon work capacity in trained and 
untrained subjects. 
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Figure 1.2 Work measures after supplementation with either placebo or antioxidant mixture of 
beta-carotene, vitamin C, and vitamin E in trained subjects. 
 
Objectives 
 
1. To examine whether supplementation with an antioxidant vitamin mixture will affect 
fatigue in exercising muscles, in normal healthy untrained subjects 
2. To examine whether supplementation with an antioxidant vitamin mixture will affect 
fatigue in exercising muscles, in normal healthy arm trained subjects 
3. To examine whether there is a difference in the effect of supplementing antioxidant 
vitamins upon normal healthy untrained subjects, when compared to arm-trained subjects 
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Figure 1.3 Work measures after supplementation with either placebo or antioxidant mixture of 
beta-carotene, vitamin C, and vitamin E in untrained subjects.(Note: n=1 for placebo) 
 
Hypothesis 
 
It is expected that there would be a group by condition interaction (p<0/10) such that 
acute (one day) and chronic supplementation (28 days) with the antioxidant mixture (beta-
carotene, vitamin C, vitamin E) would result in a decreased rate of fatigue in the untrained as 
compared to the placebo, but not in the trained. Additionally, while empirical, it is also expected 
that a greater quantity of work will be observed in the untrained following chronic 
supplementation when compared to acute supplementation, but that this would not be evident in 
the trained subjects. 
Limitations / Delimitations 
Because of the proximity of the subject pool at the university, the age of our subjects will 
be age 18 to 30. Therefore, the results may not be applicable to the ages outside this population. 
A food diary will be used to assess group antioxidant status, and accuracy of those diaries will be 
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dependent upon subject compliance. Only serum vitamin C will be measured from blood 
samples. Due to the multifaceted aspects of fatigue (i.e. neuromuscular, CNS, muscular blood 
flow, calcium availability, etc.), altering one aspect may not cause a sufficient detectable change 
in work measures. Finally, the exercise protocol will involve performing arm curls on the 
dynamometer, thus the results may not be applicable when discussing other exercises or other 
muscle groups. 
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Table 1.3 Previous Studies Using Antioxidants 
Author Exercise 
Mode 
Nutrient Result Placebo 
Controlled 
Subjects 
 
LeBlanc 1998 outdoor 
running 
beta-carotene improved 5K race 
time 
yes trained 
runners 
Novelli 1990 swimming vitamin E increase exhaustion 
time  
yes Mice 
Sumida 1988 cycle 
ergometer 
vitamin E no difference no healthy 
male 
volunteers 
Lawrence 1975 swimming vitamin E no difference yes trained 
swimmers 
Spioch 1966 step test vitamin C decrease in O2 
consumption, debt, 
and pulse rate 
no healthy 
male 
volunteers 
Samanta 1985 9-minute walk 
/ run 
vitamin C improved walk 
distance 
yes physically 
active 
students 
Gey 1970 12 minute run vitamin C improved run 
distance (less than 
1%), not statistically 
sig. 
no air force 
officers 
Keren 1980 cycle 
ergometer 
vitamin C no improvement in 
VO2 max
yes untrained 
subjects 
Allesio 1997 cycle 
ergometer 
vitamin C higher oxidative 
stress in placebo 
yes healthy 
subjects 
Sacheck 2000 downhill 
running 
vitamin E low vit E vs high vit 
E: No change in 
Oxidative stress 
no trained 
rowers 
van der Beek 
1990 
cycle 
ergometer 
vitamin C low vit C vs suppl vit 
C: no change in 
VO2max or OBLA 
yes healthy 
subjects 
Bryant 2003 cycle 
ergometer  
vitamin C and 
E 
lower lactic acid (not 
sig.): higher 
malondialdehyde in 
vit C compared to 
placebo  
yes trained 
cyclists 
Dawson 2002 half marathon 
run 
vitamin C and 
E 
no difference 
between groups in 
CK, myoglobin, 
malondialdehyde 
yes trained 
runners 
 
Lang 1986 run to 
exhaustion 
vitamin C improvement in 
endurance capacity 
yes  guinea pigs 
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Chapter 2 Methods 
Subjects 
  Thirty-one healthy subjects, both male and female, were recruited from student 
populations at a local university, and at a local health club. Of those volunteers only ten 
completed the entire protocol (see the next chapter for details).  None of the participants were 
currently taking medication, nor were they currently supplementing with antioxidant vitamins. 
Informed consent was obtained from each subject. 
 The subjects were assigned to one of  two groups: a trained group (Tr); and an untrained 
group (Untr). Untrained were defined as individuals who did  not currently participate in any arm 
resistance training activities. Trained subjects were those who were currently participating in an 
arm resistance training program at least one day per week. In addition, trained subjects must 
have been training for a minimum of one year. Each subject compiled a 3-day food diary to 
assess antioxidant vitamin status, and underwent  an initial arm curl exercise protocol on the 
dynamometer, as a practice run, before supplementation. This allowed each participant to 
become accustomed with the requirements of the subsequent exercise tests. 
Supplementation Protocol 
Before the supplementation protocol began, each subject compiled a 3-day food diary to 
assess antioxidant vitamin status. The diary length was selected based upon previous research 
that showed that  beyond this time period, the quality of record keeping declines (Gersovitz et al, 
1978; Lee and Nieman, 2003;). Subjects’ diaries were assessed for RDA levels of the selected 
vitamins using the software Food Processor for Windows (version 7.30) by ESHA Research. 
This allowed estimation of the extent to which the RDA for the selected antioxidants was being 
met, or exceeded, in the regular diet.  
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 Subjects ingested either one antioxidant capsule consisting of 25,000 international units 
(IU) of vitamin A in the form of beta-carotene, 400 IU of vitamin E, and 500 milligrams (mg) of 
vitamin C, or one  placebo capsule.  The provided capsule was ingested at the same time of day 
for 28 days following the initial pre-supplementation fatigue test. The antioxidant capsules were 
produced by Vitamin World, Inc. according to the standards of the United States Pharmacopeia / 
National Formulary requirements. After supplementation, subjects underwent a 28 day washout 
period to allow antioxidant levels to return to normal. At this point, the capsules were crossed 
over, and each individual ingested the other tablet for 28 days. All subjects were given a 28 day 
supply of capsules at the beginning of each supplementation period, and compliance was 
ascertained by the number of capsules remaining at the end of each specific supplementation 
period. 
Exercise Fatigue Testing Protocol 
 The exercise fatigue testing procedure consists of an initial practice test using a Biodex 
dynamometer, and subsequent tests at Day-1 and Day-28 of each supplementation period. The 
subjects were  unaware that the first session (the preceding the supplementation period) was not 
being recorded.  For each of the subsequent tests, each subject was tested within a 12-hour range 
of the original test. For example, if the original test was at noon, then the tests at Day-1 and Day-
28 were between 6:00 a.m. and 6:00 p.m. on those days.  The exercise protocol consisted of 
seven sets of arm curl exercises, using the non-dominant arm, with a1-minute rest between each 
set.  One set consisted of 20 repetitions. The speed of movement was set at 60 degrees per 
second for flexion, and a maximum of 400 degrees per second for extension (this speed allowed 
subjects to relax on the eccentric phase). The subjects were instructed to give all out effort for 
each set. Subsequently, total work (force multiplied by distance) for each set was measured by 
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the dynamometer, and used as the measure of fatigue. Only the total work from the last three sets 
was used in determining fatigue. 
Blood Analysis. 
 Serum vitamin C levels were assessed during the washout period and one day before the 
end of the second supplementation period. Vitamin C was assessed using the method developed 
by Dr. Richard Tulley (Tulley, 1992) in which serum samples are analyzed using the Beckman 
CX5 clinical chemistry analyzer. Each subject had blood samples drawn at the end of the 
washout period and one day before the end of the second supplementation period. Blood draw 
and analysis were performed at the Pennington Biomedical Research Center, Baton Rouge, 
Louisiana. 
Data 
 Total work for each set was collected for each subject, for each supplementation phase. 
Thus, each subject performed seven sets of the exercise on five separate occasions. Only the last 
three sets of the last four sessions, however, were used in the fatigue calculations. To examine 
the effect of supplementation upon fatigue, the total work of the last three sets was summed, and 
used for statistical comparison and  analysis using the SAS statistical software. 
Power Analysis 
In order to determine sample size a power analysis was carried out by the SAS software. 
In consultation with Mr. Xiaobing Fang (M.S., Experimental Statistics, Louisiana State 
University) it was decided that, because more than one main effect was to be considered, power 
for the study would be determined by the method described by Kuel (2000, pp. 63): 
The power of a test of hypothesis is the probability of rejecting a false null hypothesis. 
The statistics Fo =MST/MSE is used to test the null hypothesis Ho: Ji = 0. The power of 
the test is 1 – $ = P(F > F ", <1, <2 | Ho false), where <1 and <2 are the numerator and 
denominator degrees of freedom, respectively. When Ho is false, Fo has the non-central F 
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distribution and non-centrality parameter. If the null hypothesis is true, then the non-
centrality parameter is zero and Fo has the central F distribution.  
 
Based upon this method a SAS program was designed to estimate sample size with the target for 
power the interaction of supplement and time at 0.70 (Appendix B)(the program gives a number 
of sample size, alpha level, and power combinations). Based upon this calculation it was 
determined that for a power = 0.8, and an alpha level = 0.10, there would be 28 subjects required 
for the later study. The final study will be a crossover design as opposed to the pilot study. This 
may allow for less variation than the original study. 
Statistics 
 Following data collection all results will be analyzed and compared for significance. A 
mixed model two-way repeated measures ANOVA with an alpha level of p<0.10, was used to 
compare within and between group differences in the work measures. The repeated measures 
will be acute placebo, chronic placebo, acute vitamin, and chronic vitamin. For the serum 
vitamin C measures a paired t-test will be used to compare placebo and  supplementation phase 
vitamin C levels. 
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Table 2.1 Timeline For the Study 
Days 1-7 Subjects record diet for three days. At the beginning of the 
recording period, subjects will have the initial assessment on 
the dynamometer. 
Day 14 and 15 Subjects begin the supplementation period. On the second day, 
they will again be assessed on the dynamometer. 
Day 42 Subjects continue supplementation, and on the twenty-eigth 
day are assessed on the dynamometer  
Day 44 - 70 Subjects undergo washout period 
Day 71 and 72 Subjects begin the second supplementation period. On the 
second day, they will again be assessed on the dynamometer. 
Day 100 On the last day of supplementation, subjects will again be 
assessed on the dynamometer 
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Chapter 3 Results
Subjects
The study originally began with 31 subjects. Out of that group 20 completed the first 
supplementation phase, but did not participate in the crossover. Ten subjects completed the entire 
study and participated in both phases. Subjects were selected from kinesiology courses at the 
university. The mean age of all subjects was 20.9 years with a maximum of 23 years and 
minimum of 19 years (Table 3.1). All completed a statement of informed consent (Appendix D). 
 Each subject completed a twenty-eight day supplementation period followed by a 
one month washout period then, followed by another twenty-eight day supplementation period. 
They were instructed to pick up their packet of twenty-eight capsules one week prior to the 
beginning of each supplementation period. There were two packets - one containing the placebo, 
and the other the antioxidant mixture. Because the study was double blind, neither the 
investigator nor the subjects had knowledge of the contents of the packet that each received at 
the specified intervals. 
Table 3.1 Subjects Descriptive Statistics 
N Mean Std Dev Std Err Max Min
10 20.90 1.101 0.348 23.00 19.00 
Food Diary Measures
Subjects completed a 3-day food diary to assess current intake for the antioxidants being 
ingested. The information therein was analyzed using the software, Food Processor for Windows 
(version 7.30) by ESHA Research, as described earlier. The results for each subject are listed in 
table 3.2. The means for each antioxidant are listed for each subject for the three day period. 
Descriptive statistics were calculated and appear in table 3.3. 
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Table 3.2 Antioxidant Vitamin Measures From Food Diary Data 
Subjects Status
Beta-car. 
(mcg)
Vitamin C 
(mg)
Vitamin E 
(mg)
1 Trained 811.12 98.42 2.68 
2 Untrained 498.62 87.89 5.30 
3 Trained 3122.46 1017.19 14.56 
4 Untrained  1388.48 63.19 4.21 
5 Untrained 330.18 99.37 3.98 
6 Trained 9.38 31.12 4.96 
7 Trained 574.32 107.25 8.50 
8 Untrained 223.93 102.29 1.58 
9 Trained  7494.26 31.42 2.72 
10 Trained 3461.40 118.31 18.29 
Table 3.3 Descriptive Statistics for Antioxidant Intakes  
Nutrient N Mean Std Dev Std Err
beta-car (mcg) 10 1791.415 2336.351 738.819 
vitamin C (mg) 10 175.645 297.277 94.007 
vitamin E (mg) 10 6.678 5.539 1.752 
Serum Vitamin C Levels
Subjects were asked to volunteer to give  blood samples during the 27th day of each 
supplementation phase. Blood samples were analyzed for vitamin C content at the clinical 
chemistry laboratory at the Pennington Biomedical Research Center in Baton Rouge, Louisiana. 
A 5.0 milliliter sample was collected from each subject at each blood draw. Samples were 
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analyzed using a Beckman Synchron CX5 Chemistry Analyzer. The method is the same 
described by Tulley (1992) and currently used at Pennington. 
 Eight of the ten subjects volunteered to have their blood analyzed. Table 3.4 lists the 
results of the blood sample analysis for each subject. As indicated, blood was drawn one day 
before the end of each supplementation protocol. Each subject had one sample taken while on the 
placebo and one taken while on the antioxidant mixture. 
Table 3.4 Vitamin C Sample Results 
Subject # Placebo Vitamin C
1 13.20 16.30 
2 10.40 11.40 
3 6.10 23.60 
4 10.50 17.40 
5 8.20 9.30 
6 9.20 9.40 
7 4.70 6.20 
8 2.30 12.10 
 Following vitamin C data collection, a statistical analysis was performed to obtain 
descriptive statistics and to observe any differences between the two supplementation periods. A 
paired t test was chosen to describe any differences. Table 3.5 lists the descriptive statistics for 
the vitamin c samples. 
Table 3.5 Vitamin C Samples Descriptive Statistics 
N Mean Std Dev Std Err
placebo 8 8.075 3.535 1.250 
vitamin 8 13.213 5.587 1.975 
Results of the paired t test are presented in table 3.6, and show significant differences 
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(p=0.046) between samples taken while subjects were on the placebo compared to those took 
while subjects were on the antioxidant mixture. Results of the paired t test show that serum 
vitamin C levels increased following the antioxidant supplementation when compared to the 
placebo samples. 
Table 3.6 Vitamin C Samples Paired T-Test 
Mean Std Dev Std Err Mean Diff T Value Prob DF
placebo 8.075 3.535 1.250 
Vitamin 13.213 5.587 1.975 -5.138 -2.418 0.046 7 
Arm Curl Exercise Measures
Following the arm curl exercise, work achieved for each set was recorded in joules for 
each subject. Table 3.7 shows the results for each subject at each phase of supplementation. The 
protocol was performed on a Biodex dynamometer in the kinesiology lab at Louisiana State 
University.  Figure 3.1 indicates the acute vitamin condition was 4% lower when compared to 
the chronic vitamin condition, in the trained subjects. The untrained subjects were 3% lower 
from the chronic placebo compared to the acute vitamin condition, and a 7% from the acute 
vitamin compared to the chronic vitamin condition (Figure 3.2). 
 A two-way repeated measures ANOVA was performed to detect any differences. The 
ANOVA results are listed in table 3.8. There was no significant difference for the main effect of 
suppstatus (acute placebo, chronic placeboe, actute vitamin, chronic vitamin)( p=0.90). 
Additionally, there was no significant effect for the interaction of training and suppstatus 
(p=0.95). There was, however, significant differences for the main effect of training (train vs. 
untrain) (p=0.07). Power for all tests are low and indicate a high possibility of making a Type II 
error (Table 3.9). Power was determined by the SAS software (Appendix C) using the method 
described by Kuel (2000, pp. 63).  
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Table 3.7 Work Measurements for Each subject 
Subject Acute Plac Chronic Plac Acute Vit Chronic Vit training
1 1006.00 1768.50 1877.80 2262.70 trained 
2 773.40 616.70 1096.10 789.30 trained 
3 2489.00 2780.10 1854.60 1577.20 trained 
4 1819.40 2400.40 3007.80 2787.30 trained 
5 1372.20 1046.90 1347.10 1199.40 trained 
6 752.10 1271.40 1359.40 1489.60 trained 
7 1042.50 1089.60 1267.20 1037.60 untrained 
8 2101.70 2425.50 1834.20 1800.50 untrained 
9 966.60 844.30 1078.80 1159.20 untrained 
10 504.60 616.30 670.60 528.40 untrained 
 To summarize, it appears that the supplementation protocol did not have a significant 
impact upon work output although there is a significant main effect of training (p=0.07). Clearly, 
no statistically significant change in work output was seen under either condition, trained or 
untrained. Additionally, power is too low to make a decision without risk of Type II error, 
regarding the research hypothesis. 
Table 3.8 Two Way Repeated Measures ANOVA for Work Results 
Source DF SS MS F Pr
train 1 1765764.150 1765764.150 3.62 0.07 
suppstatus 3 274571.469 91523.823 0.19 0.90 
train X 
suppstatus 3 180431.321 60143.774 0.12 0.95 
error 32 15604409.30 487637.79   
total 39 17922768.64    
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Table 3.9 Power Measurements at Alpha = 0.10 
Effect Power
train 0.476 
supp <0.10 
trainX suppstatus <0.10 
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Figure 3.2 Work Output for Untrained Subjects 
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Chapter 4 Discussion 
Antioxidants are continuously marketed to athletes and fitness enthusiasts as being 
beneficial to muscular performance (ADA, 2000). This is because there is a concomitant increase 
in oxygen consumption during muscular work which results in an accompanying increase in free 
radicals and other ROS. Nevertheless, the human body has developed a system of enzymatic and 
non-enzymatic antioxidants that help to protect it during “steady state” (Powers and Hamilton, 
1999; Powers and Lennon, 1999) . However, during times of increased work these systems may 
be overwhelmed and impair the ability of a muscle to sustain a given level of work production.  
 Studies have investigated the possibilities that supplementing exogenous antioxidants 
beyond the RDA for those nutrients that may have a beneficial effect against the deleterious 
consequence of an increase in ROS. These antioxidants, beta-carotene, vitamin E, and vitamin C 
have been studied individually in exercising subjects with mixed results.  
 This investigation supplemented subjects with a combination of these three antioxidant 
nutrients in an attempt to answer questions regarding their affect upon muscular work. Very few 
studies have investigated these substances together, and none have used a protocol similar to the 
one used in this study. Based upon previous literature and the pilot study mentioned earlier, this 
more thorough investigation was carried out. To this end it was decided that an intermittent work 
protocol using trained and untrained subjects, who were not deficient in any of the tested 
antioxidants was the ideal design. 
Food Diary Measures 
Vitamins C and E, and beta-carotene intakes were estimated using 3-day food diaries. 
Each subject was given a diary to completely record everything that was eaten during  a 3-day 
period. As invasive measures of these two of the nutrients were not investigated,  it was 
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determined that recording daily intake of these nutrients would provide the best estimate of tissue 
levels for this particular group. Assessment of the subjects’ status in regards to the antioxidants 
studied, was necessary to ensure that there were none of them starting from a point of deficiency, 
prior to the start of the experiment.  
Currently there is no RDA for beta-carotene in humans. However, the RDA for vitamin A 
is 0.8 - 1.0 retinol equivalents (RE) (Groff et al, 1995). Beta-carotene is a precursor to vitamin A, 
and is often called pro-vitamin A. The body cleaves stored beta-carotene as needed to maintain 
serum vitamin A levels within the body. There appears to be no serious side effects when 
ingesting beta-carotene in excess of the RDA for vitamin A because it is not converted to vitamin 
A until the body needs it.  
Following diet analysis for each subject, the software displayed information for each 
vitamin and mineral with an RDA and also other nutrients, such as beta-carotene, that do not 
currently have an RDA. The Food Processor for Windows software reported total vitamin A / 
provitamin A in the diet. It also provided beta-carotene content as a separate measure from total 
vitamin A content. Our subjects mean intake for beta-carotene during the 3 days of listing food 
intake was 1791.415 mcg (Table 3.3). Six micrograms of beta-carotene is equal to one RE. 
Again, this measure was just a part of the total vitamin A intake, but it does illustrate the extent 
to which the subjects were meeting the RDA for vitamin A. On average the subjects ingested 
298.57 RE per day for the three day period. This far exceeds the RDA for vitamin A and ensures, 
barring any malabsorptive disorders (pancreatic, liver, or gall bladder diseases), that the subject 
pool was not vitamin A deficient prior to the supplementation regimen (Beta-carotene ingestion 
for each subject is listed in table 3.2). 
The RDA for vitamin E is 8 mg and 10 mg tocopherol equivalents (TE) per day, for 
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women and men respectively. The normal intake for vitamin E in American diets is 4 mg TE to 
22 mg TE/day for individuals not supplementing their diet with exogenous vitamin E (Di Mascio 
et al, 1991). Again, vitamin E requirements increase as the intake of PUFA increases or 
decreases. Because of this dependency upon PUFA content, determining a precise requirement 
for vitamin E has been difficult. However, because most foods high in PUFA are also high in 
vitamin E, there is not much fear of deficiency. In fact, vitamin E deficiency in humans is very 
rare. As in the case with beta-carotene, deficiency in adults is only seen in those suffering from 
malabsorption diseases, especially those that affect the absorption of fats. 
The diet analysis determined that the mean intake for vitamin E for each subject for the 
three day period was 6.678 mg TE/day (Table 3.3). This is just below the RDA for vitamin E but 
is well within the normal intake for those consuming a typical American diet (Di Mascio et al, 
1991). This also falls between the range stated by Guthrie and Picciano (1995), between 5 and 20 
mg TE/day, that would be considered safe depending upon PUFA intake. Considering the rarity 
of vitamin E deficiency, and the fact that our subjects intake of vitamin E falls between the range 
for normal intake, it is highly unlikely that these subjects were vitamin E deficient before 
beginning the supplementation regimen. 
The RDA for vitamin C is 60 mg/day for adult men and women. This amount was chosen 
based upon the amount required to maintain a body pool of 1500 mg (the amount of vitamin C 
that can be held within the body without excretion via the kidneys). The subjects’ food diaries 
showed that the mean intake for each subject per day was 175.645 mg of vitamin C per day 
(Table 3.3). This number exceeds the amount in the RDA, but is far below the amount indicated 
in vitamin C toxicity (Alhadeff et al, 1984). Again, it is highly unlikely that subjects were 
vitamin C deficient before beginning the supplementation protocol.  
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Serum Vitamin C Levels 
Blood samples were collected from each subject on the 27th day of supplementation, and 
subsequently analyzed for serum vitamin C levels. Serum vitamin C analysis was carried out at 
the Pennington Biomedical Research Center clinical chemistry laboratory, as previously noted. 
Each subject was tested while supplementing on both placebo, and vitamin C. While on the 
placebo, mean serum vitamin C levels (Table 3.5) were 8.075 mg/L, which is well within normal 
values (5 - 15 mg/L) for adequate vitamin C status (Tietz, 1997). Following the 28 day vitamin C 
supplementation period (which followed a twenty-eight day washout period) mean serum 
vitamin C levels increased to 13.213 mg/L. The subsequent paired t-test for differences showed a 
significant difference between placebo and vitamin C periods (p=0.046)(Table 3.6). 
Clearly the supplementation of exogenous vitamin C was well tolerated, and had an affect 
upon subjects’ serum vitamin C. The increase in serum vitamin C tends to support the 
absorbability of the chosen supplement which, as was indicated, fully complied with United 
States Pharmacopeia / National Formulary requirements. It also supports that supplementing with 
vitamin C increases plasma vitamin C levels (Polidori et al, 2004).  
The increase in vitamin C also gives insight into the status of another antioxidant used in 
this study. As long as the levels of serum vitamin C are at or above normal levels we can expect 
vitamin E to act as an antioxidant rather than a pro-oxidant. Only when vitamin C levels are 
below normal can we expect a reduction in vitamin E levels because of ascorbate’s crucial role in 
regenerating the alpha-tocopheroxyl radical (Kontush et al, 1996; Brown et al, 1997; Chan, 
1993). As we have seen vitamin C levels increase significantly, we feel confident in the fact that 
vitamin E and beta-carotene was well tolerated, and  increased the total body pools of both in 
each subject. 
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Power and Significance 
During this study there were a number of subjects who dropped out at various points 
throughout the protocol. The study began with thirty-one subjects and ended with ten who 
completed the entire protocol. Since sample size is one of the factors affecting power (Norton 
and Strube, 2001; Thomas and Nelson, 2001;) any loss in subjects will have a profound effect 
upon power. Power allows for a level of confidence that the decision to be made from statistical 
results is the correct decision, or more simply put, it is the probability of not making a Type II 
error (failing to reject the null hypothesis when it is false) (appendix E). The power analysis for 
this study revealed extremely low power for the main effects as well as their interaction. Power 
for supplementation status, training, and their interaction was <0.10, 0.35, and <0.10 
respectively. Therefore, due to the  the loss of power in the study, we cannot have confidence 
that we would not make a Type II error if we were to accept the null hypotheses. The low power 
almost guarantees making a Type II error. 
Variability is another factor that may affect power. Each of the main effects, and the 
interaction have large variances in this study. For instance, if the distribution of scores were 
represented by a curve, the narrower the curve is the smaller the variability about the mean; 
conversely, the wider the curve the greater the variability about the mean (Norton and Strube, 
2001). If there were a pair of distribution of scores on the scale, the wider the range of scores the 
more overlap there would be between the two curves. If one of those curves represents the 
assumption that the null hypothesis is true and the other represents the distribution based upon 
the research hypothesis being true, the more overlap there is between the scores the less chance 
there is of detecting a real difference. As the overlap becomes larger beta increases and thus, 1 - 
beta, or power, decreases. As the main effects and interaction variances are large in this study 
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(appendix C) the variability, as well as the number of subjects, has also had an effect upon the 
power of this study. In addition, the variability makes the reproducibility of this study very 
difficult under the same conditions. Consequently, it is with these facts in mind that we will 
report the results and any inferences that may be taken from them. 
 Acute Supplementation Work Values 
Subjects were supplemented with a placebo and the antioxidant vitamin mixture (beta-
carotene, vitamin E, and vitamin C) to see if an acute dose would cause an affect upon the work 
capacity during the arm curl protocol. As was noted, there is scant research investigating the 
affect of an acute (one day) ingestion of either of the three antioxidant nutrients upon muscular 
fatigue during the arm curl protocol prescribed in this study. In addition, no studies using the 
intermittent arm curl protocol were found throughout the literature. 
Neither untrained nor trained participants showed a significant difference in work values 
from the acute placebo to chronic placebo phase (untrained p=0.86; trained p=0.49). Nor were 
there any significant differences between the chronic placebo and acute vitamin phase (untrained 
p=0.95; trained p=0.79). The chronic placebo was 3% lower when compared to acute vitamin 
phase, and the acute vitamin was 7% lower when compared to chronic vitamin phase in work 
output. However, with the significance level and power of the analysis we cannot make a 
conclusion about this and have little confidence in the decrease seen in these work values. Again, 
the unanticipated dropout rate of the subjects have resulted in the low power of the test, and 
make it highly likely to commit a Type II error (appendix E). 
Chronic Supplementation Work Values in Untrained 
Chronic supplementation work values in untrained subjects were compared following the 
supplementation period. As in the case of the acute supplementation, scant research exists that 
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compares the influence of this antioxidant mixture upon muscular work capacity during an 
intermittent work protocol.  In the untrained subjects no significant difference in work was 
observed from the chronic placebo supplementation to the acute vitamin supplementation 
(p=0.95), nor from the acute vitamin to chronic vitamin supplementation (p=0.87). Once again 
we cannot have any confidence in a determination to make because of the low power of the 
statistical analysis. So, although the p values would indicate that we should fail to reject the null, 
the power does not allow for there to be any confidence in that decision. 
Chronic Supplemenation Work Values in Trained 
  In the trained subjects, no significant difference in work was observed from the acute 
vitamin to chronic vitamin supplementation (p=0.86).  In a trend seen similar to that in the acute 
work values, acute vitamin was 4% lower compared to the chronic vitamin phase in the trained 
group. Again, normally at the current p value, we would fail to reject the null. However, the low 
power indicates the high probability for Type II error. So, we would have no confidence in 
making that determination. Although there may be a trend seen, this would make any percent 
changes in work statistically meaningless. 
Main Effects and Interactions 
When comparing the main effects for trained vs the untrained state there is a significant 
difference observed (p=0.07) which, was not unexpected. We would expect the trained subjects 
to have higher work values than untrained subjects simply because of their constant training state 
throughout the investigation. 
For the interaction of the supplement status (acute placebo, chronic placebo, acute 
vitamin, chronic vitamin) and training (trained, untrained), p=0.95 (table 3.8). It was 
hypothesized that there may be a significant interaction between the two however, p value 
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indicates no significance. Additionally tables 3.1 and 3.2 graphically show no apparent 
indication or trend towards an interaction between the two states (trained or untrained) under any 
of the four supplemental phases. 
Antioxidant Status 
Much of the research in this area has been observing the influence of single antioxidants 
upon work capacity rather than the antioxidant mixture (beta-carotene, vitamin E, vitamin C) 
employed  in the present study. However, also of note, was the lack of data concerning the 
antioxidant nutrient status of subjects before participation in said studies. Some lacked the 
information altogether  (Spioch et al, 1966; Gey et al, 1970; Keren and Epstein, 1980; Allesio et 
al, 1997; Novelli et al, 1990; Sumida et al, 1988; Lawrence et al, 1975), and one reported that 
subjects were deficient in the selected antioxidant (LeBlanc, 1998) before supplementation 
began. In this study, there was an effort to establish that each subject was not deficient in any of  
the supplemented antioxidants (Table 3.2) before beginning the supplementation period. 
Descriptive statistics for each nutrient for each subject were analyzed and showed deficiency to 
be unlikely in the subject pool. This was performed to ensure that any differences observed were 
not caused by a subject’s being deficient in any of the antioxidant nutrients. The ADA and 
American College of Sports Medicine report that most athletes do not require supplementation of 
vitamins and minerals above the current RDAs (ADA, 2000). This is because most athletes are 
consuming a larger amount of food than normal healthy individuals. This high intake usually 
ensures that they are not deficient in most nutrients. It is more than likely that our trained 
subjects would fit this profile. The exception is made in the case of those athletes who “restrict 
energy intake, eliminate one of the four food groups from their diet, or consume high 
carbohydrate, low micronutrient-dense diets”. 
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Limitations and Other Concerns  
There are a number of pitfalls that may have hampered the ability of the current study to 
detect differences and obtain sufficient power. First would be the unexpected drop out rate of the 
participating subjects. There is no apparent reason for the high attrition rate that is seen in this 
study. In previous pilot work the unusually high attrition rate was not observed and there was no 
indication that it would transpire here. Subjects used in the current study were university 
students. Based upon some of the motivational techniques recommended in Appendix F, I 
arranged, with their professors, for the subjects to receive extra points toward their final grade in 
the class that I drew them from (they were drawn from a pool of four classes at the university). 
As it turned out, many of the students dropped the class they were in and thus, dropped out of the 
study. Some students forgot about their appointment date in the lab and were dropped. Clearly, 
this has had the largest impact upon the study.  
Still those that participated were instructed to give an all out effort on each set of arm 
curls. If they did not give the effort required this may also have an effect upon the results. If 
subjects are just “going through the motions” it would make it difficult to see any changes in 
work values over the four trials. This may be a result of lack of motivation or boredom. Perhaps 
having meetings at different times throughout the study could have served as a time to renew 
motivation that may have waned since the start of the study (Appendix F). 
The subjects were instructed to take the capsules everyday with a meal. However, there 
was no way of knowing if they actually followed this advice. It is conceivable that some students 
missed days and attempted to “double up” by taking their missed dosage and their scheduled 
dosage at the same time. If this were done on more than one occasion by more than one subject 
this may have an effect upon the work values as well because of the antioxidant levels that are 
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affected. 
The subjects in the study were found to be at the normal intake for the antioxidants after 
food diaries were measured. Upon observation it may have been beneficial to look at subjects 
who were restricted in their diet. Those athletes / individuals who are more likely to have a 
restrictive diet (i.e. middle distance runners or swimmers ) may have shown more of an effect 
under the intermittent work protocol that was used here. Those who are more prone to restrict the 
intake of PUFA or fruits and vegetables may have exhibited a lower than normal intake of 
vitamin E and / or vitamin C. We used college students who were either engaging in strength 
training regularly or who did no strength training at all. However, none were preparing for a 
competition as an athlete would, and so they did not exhibit the kind of restrictive diet that the 
aforementioned athletes may. Finally, and perhaps most importantly, we trusted that the subjects 
completed their food diaries accurately and truthfully. If they did not this may also have had an 
effect upon the outcome of the study. The fact that analyzing serum vitamin E and / or beta-
carotene levels was financially beyond the scope of this study, was a limitation that we were well 
aware of. It may be that these measures would have told a different story concerning subjects 
status for the selected antioxidants. 
The exercise protocol chosen may not elicit a large enough oxidative stress to see the 
results that were anticipated. Arm curls involve mainly the biceps brachii. Perhaps had the 
protocol involved knee extensions or leg presses this would have caused a high enough oxygen 
demand to observe an affect of the antioxidants. In the future this should be considered when 
examining these supplements in a similar manner. 
As has been discussed, fatigue is a very complex concept in regard to the human body. 
There are many factors that can contribute to fatigue including physiological and psychological 
 66
(Astrand, 1986) components. Among those previously mentioned are substrate depletion 
(depending upon the intensity of the exercise), muscle oxidation-reduction state, psychological 
state / mood, CNS fatigue, and local blood flow. 
This study set out to investigate the effect supplementation with the beta-carotene, 
vitamin C, and vitamin E would have upon work capacity during an intermittent work protocol 
of seven sets of arm curls with one minute rest between each set. As oxidative stress has shown 
to play a part in muscular fatigue (Reid, Hack et al, 1992; Novelli et al, 1990) the theory was that 
supplementing with these antioxidants would help to affect the amount of work being produced 
through their neutralizing some ROS. Nonetheless, it may be possible that indeed they did help 
neutralize some of the ROS, but perhaps that the effect is so small as to not make a noticeable 
difference. To measure this effect, determining the work using the dynamometer may not be the 
best method. Perhaps another invasive measure unknown to this investigator is available to 
determine this effect. 
As this study involved the arm curl protocol and the measurement of work by the 
dynamometer, there was no way to address the possibility of there being a psychological factor 
contributing to fatigue. The protocol was not set out to evaluate psychological factors 
contributing to fatigue. It may be possible that psychological factors have played a part in this 
study. As mentioned earlier mood, plays a large part in fatigue. If subjects were not in a good or 
“energetic” mood, or had feelings of depression this may have had an effect upon the results of 
their tests on the dynamometer. Unfortunately, this cannot be accounted for under the conditions 
set forth. 
Neural fatigue was not evaluated during this study. Although it seems unlikely that CNS 
fatigue was a factor, according to the results by Merton (1954), there was not a way to evaluate 
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this on the dynamometer in the laboratory. However, this type of fatigue would more than likely 
be measured with an EMG. This is available in the university laboratory and should be 
considered for the future when a study of this undertaking is being considered. In addition, blood 
flow was not evaluated under the current study conditions. Although, this measure would 
probably be determined with some kind of blood flow occlusion device (similar to a blood 
pressure cuff). However, this seems unlikely as this kind of device may have created more of an 
oxidative stress than without. 
It is unfortunate that this study had such a high attrition rate and thus, low power. In the 
future there are some suggestions to enhance the chances of having a larger power measurement. 
Perhaps an increase in the number of subjects in the study, or longer supplementation period 
would help to guard against the high attrition rate, or allow a stronger effect of the supplement. 
Also, an increase in the number of subjects from a more diverse population or specialized 
population (i.e. diet restricted athletes, the elderly, all women, etc.) will shed more light upon the 
possibilities. Subjects were primarily college age students from a university population. If 
subjects were taken from a wider age range and a larger pool we may see significant differences. 
For this study we used the population that was most accessible. It may be that this trend would 
not prove to be significant with these changes. However, if it were found to be significant this 
would give some validity to the notion that supplementation with exogenous antioxidants is not 
only of no benefit but, possibly detrimental to muscular performance during exercise. 
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Chapter 5 Summary and Conclusions 
The purpose of this study was to investigate the possible effect that supplementation with 
a mixture of beta-carotene, vitamin C, and vitamin E may have upon fatigue, during a protocol of 
intermittent work. Exercise has been shown to increase the proliferation of free radicals and ROS 
within working muscles due to an increase in oxygen consumption (Powers and Hamilton, 
1999). The antioxidants beta-carotene, vitamin C, and vitamin E have been shown to neutralize 
some ROS within tissue cells. Manufacturers market these antioxidants as being necessary to the 
general public, but also to athletes and fit individuals specifically (ADA, 2000). Although 
research has shown that athletes usually ingest more than the RDA for most nutrients through 
their diet alone, the supplementation of antioxidants is still promoted by these manufacturers. 
It has been demonstrated that the proliferation of ROS during muscular work can 
contribute towards fatigue in working muscles (Reid and Haack, 1992). To this end, investigators 
have attempted to test if supplementation with non-enzymatic antioxidants would have an effect 
upon muscular work. Results have been inconclusive, and have not looked at how combining the 
three selected antioxidants (beta-carotene, vitamin C, vitamin E) may influence muscular work. 
Therefore, this study was designed to investigate the following hypothesis: 
There would be a group by condition interaction (p<0/10) such that acute (one day) and 
chronic supplementation (28 days) with the antioxidant mixture (beta-carotene, vitamin 
C, vitamin E) would result in a decreased rate of fatigue in the untrained as compared to 
the placebo, but not in the trained. Additionally, while empirical, it is also expected that a 
greater quantity of work will be observed in the untrained following chronic 
supplementation when compared to acute supplementation, but that this would not be 
evident in the trained subjects. 
 
Results indicated that there was no effect of the antioxidant supplementation protocol 
upon muscular work during the intermittent work regimen. There was a significant effect of 
training as was expected (P=0.07), but not with the interaction of training and supplementation 
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(P=0.95). Unfortunately, because of the low power of this study, we cannot place any confidence 
in a determination made about the hypothesis. 
In the future, investigators may want to look at how a longer period of supplementation 
influences work capacity. Most athletes would not take these supplements for just a 28 day 
period as in this study. Many would take it over the course of an entire competitive season. In 
addition, what would be the dose response? Is the RDA of each nutrient enough or too much? 
Does more than that cause unwanted effects? This information would benefit this group 
specifically performance-wise, as well as financially. Also, a study with a much larger pool of 
subjects may increase power so, that determinations can be made with confidence. Afterwards if 
indeed a significant effect is found, this would be of utmost importance to not only athletes but 
fit individuals supplementing their diet as well.  
Finally, it may be of interest to investigate if the supplementation of these antioxidants is 
causing a proliferation of ROS themselves during moderate to high intensity exercise, when 
taken in excess of the RDA. We know that vitamin E and vitamin C must be regenerated after 
they neutralize any ROS. If they are not regenerated for some reason, might they be contributing 
towards muscular fatigue? This would be an interesting finding if indeed this were the case. 
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Appendix A: Food Diary Questionnaire 
 
Food Diary / Record Packet for Participants in the 
Antioxidant / Fatigue Study 
 
 These are the forms needed to report food intake for three days as required of subjects 
participating in the aforementioned study. Please follow strictly follow directions in order for 
your data to be usable. 
 
• List all foods and beverages consumed at and between meals for the three days. 
• Don’t forget such items as gravy, jams, sauces, salad dressing, nuts, candy, margarine / 
butter, milk on cereal, fruit, or social beverages 
• Record foods immediately after eating (don’t rely on your memory) 
• List separately the foods that make up one dietary item (i.e. for a sandwich list bun, type 
and amount of meat, butter, mustard, mayonnaise, etc.) 
• Express amounts of meat in ounces or grams, fruits and vegetables in cups or number of 
that particular item (i.e., one orange, one tomato, etc.) 
• Bread may be recorded as number of slices 
• Beverages should be recorded in ounces or cups 
• Include at least one day during the weekend, among the three days recorded 
 
Example: 
 
 
 Meal Time Food Description Amount 
Breakfast 8 am corn flakes  1.5 cups 
  2% milk  2 cups 
Snack 10 am Banana raw one 
Lunch 1 pm pasta cooked 1.5 cups 
  marinara sauce cooked 1 cup 
  iced tea  20 ounces 
  chicken breast cooked 8 ounces 
 
 
 
 
 
 
 
 
 
  
Day One 
 
 
Meal Time Food  Description Amount 
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
 
 
 
 
 
 
 
 
 
 Day Two 
 
 
Meal Time Food Description Amount 
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
 
 
 
 
 
 
 
 
 
 
 Day Three 
 
 
Meal Time Food Description Amount 
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Appendix B: Pilot Study Data and Power Analysis for Sample Size 
 
Pre = Pre-supplementation 
acute = One day of supplementation 
25 days = Twenty fifth day of supplementation 
 
Table B.1 Data Chart for collected results 
State Subject supp time work 
untr 1 plac pre 1163.8 
untr 1 plac acute 1385.8
untr 1 plac 25days 1314.7
untr 2 vit pre 328.9
untr 2 vit acute 326.1
untr 2 vit 25days 396.7
untr 3 vit pre 735.4
untr 3 vit acute 884.3
untr 3 vit 25days 1034.3
untr 4 vit pre 732.2
untr 4 vit acute 675.2
untr 4 vit 25days 807.7
untr 5 vit pre 806.5
untr 5 vit acute 789.4
untr 5 vit 25days 576.1
untr 6 vit pre 448.1
untr 6 vit acute 796.9
untr 6 vit 25days 719.6
tr 7 plac pre 516.2
tr 7 plac acute 622.4
tr 7 plac 25days 690.2
tr 8 plac pre 1513.3
tr 8 plac acute 1801.5
tr 8 plac 25days 2080.4
tr 9 plac pre 1290.4
tr 9 plac acute 1545.6
tr 9 plac 25days 1501.2
tr 10 plac pre 826.8
tr 10 plac acute 980.4
tr 10 plac 25days 993.5
tr 11 vit pre 1378.6
tr 11 vit acute 1493.9
tr 11 vit 25days 1212.9
 84
tr 12 vit pre 1155.5
tr 12 vit acute 1154.8
tr 12 vit 25days 1021.1
tr 13 vit pre 1418.2
tr 13 vit acute 1486.9
tr 13 vit 25days 1316.3
tr 14 vit pre 1945
tr 14 vit acute 1939.1 
 
 
 
 
 
 
Figure B.1 ANOVA Results 
 
                                       
                                  Type 3 Tests of Fixed Effects 
 
                                            Num     Den 
                      Effect                 DF      DF    F Value    
Pr > F 
 
                      status                  1      12       3.09    
0.1045 
                      Supple                1      12       0.29    
0.5974 
                      status*Supple     1      12       4.67    
0.0517 
                      Day                     2      24       5.25    
0.0128 
                      status*Day          2      24       0.10    
0.9057 
                      Supple*Day        2      24       2.63    
0.0931 
                      status*Supple*Day       2      24       2.08    
0.1468 
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                                       Least Squares Means 
 
                                                           Standard 
Effect           status    Supple    Day       Estimate       Error      
DF    t Value   Pr > |t| 
 
status           tr                             1379.67      114.75      
12      12.02     <.0001 
status           untr                          982.63      194.74      
12       5.05     0.0003 
status*Supple    tr        plac         1196.82      177.78      12       
6.73     <.0001 
status*Supple    tr        vit           1562.52      145.15      12      
10.76     <.0001 
status*Supple    untr     plac        1288.10      355.55      12       
3.62     0.0035 
status*Supple    untr     vit          677.16         159.01      12       
4.26     0.0011 
Day                               25days   1212.42      116.02      
24      10.45     <.0001 
Day                                  acute   1233.88      116.02      
24      10.64     <.0001 
Day                                  pre      1097.15      116.02      
24       9.46     <.0001 
Supple*Day                 plac      25days     1315.51      204.03      
24       6.45     <.0001 
Supple*Day                 plac      acute        1311.64      204.03      
24       6.43     <.0001 
Supple*Day                 plac      pre            1100.24      
204.03      24       5.39     <.0001 
Supple*Day                 vit       25days       1109.32      110.50      
24      10.04     <.0001 
Supple*Day                 vit       acute          1156.13      
110.50      24      10.46     <.0001 
Supple*Day                 vit       pre              1094.06      
110.50      24       9.90     <.0001 
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                                Differences of Least Squares Means 
 
                                                                           
Standard 
Effect         status  Supple  Day     _status  _Supple  _Day    
Estimate     Error    DF  t Value 
 
status         tr                      untr                        
397.04    226.04    12    1.76 
status*Supple  tr      plac            tr       vit       -365.69    
229.51    12   -1.59 
 
                                       The Mixed Procedure 
 
                                Differences of Least Squares Means 
 
                                                                           
Standard 
Effect         status  Supple  Day     _status  _Supple  _Day    
Estimate     Error    DF  t Value 
 
status*Supple  tr      plac          untr     plac             -
91.2750    397.52    12   -0.23 
status*Supple  tr      plac          untr     vit                
519.66    238.51    12    2.18 
status*Supple  tr      vit             untr     plac               
274.42    384.04    12    0.71 
status*Supple  tr      vit             untr     vit                
885.36    215.30    12    4.11 
status*Supple  untr    plac         untr     vit                
610.94    389.49    12    1.57 
Day                            25days                       acute   -
21.4667   45.3770    24   -0.47 
Day                            25days                       pre       
115.27   45.3770    24    2.54 
Day                            acute                          pre       
136.74   45.3770    24    3.01 
Supple*Day             plac    25days              plac     acute     
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3.8750   79.8014    24    0.05 
Supple*Day             plac    25days           plac     pre       
215.28   79.8014    24    2.70 
Supple*Day             plac    25days           vit      25days    
206.19    232.03    24    0.89 
Supple*Day             plac    25days           vit      acute     
159.38    232.03    24    0.69 
Supple*Day             plac    25days           vit      pre       
221.45    232.03    24    0.95 
Supple*Day             plac    acute            plac     pre       
211.40   79.8014    24    2.65 
Supple*Day             plac    acute            vit      25days    
202.31    232.03    24    0.87 
Supple*Day             plac    acute            vit      acute     
155.51    232.03    24    0.67 
Supple*Day             plac    acute            vit      pre       
217.58    232.03    24    0.94 
Supple*Day             plac    pre              vit      25days   -
9.0858    232.03    24   -0.04 
Supple*Day             plac    pre              vit      acute   -
55.8942    232.03    24   -0.24 
Supple*Day             plac    pre              vit      pre       
6.1775    232.03    24    0.03 
Supple*Day             vit     25days           vit      acute   -
46.8083   43.2206    24   -1.08 
Supple*Day             vit     25days           vit      pre      
15.2633   43.2206    24    0.35 
Supple*Day             vit     acute            vit      pre      
62.0717   43.2206    24    1.44 
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Differences of Least Squares Means 
 
            Effect         status  Supple  Day     _status  _Supple  
_Day    Pr > |t| 
 
            status         tr                      untr                    
0.1045 
            status*Supple  tr      plac            tr       vit            
0.1371 
            status*Supple  tr      plac            untr     plac           
0.8223 
            status*Supple  tr      plac            untr     vit            
0.0500 
            status*Supple  tr      vit             untr     plac           
0.4886 
            status*Supple  tr      vit             untr     vit            
0.0014 
            status*Supple  untr    plac            untr     vit            
0.1427 
            Day                            25days                    
acute                 0.6404 
            Day                            25days                    
pre                    0.0180 
            Day                            acute                     
pre                      0.0060 
            Supple*Day             plac    25days           plac     
acute     0.9617 
            Supple*Day             plac    25days           plac     
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pre         0.0126 
            Supple*Day             plac    25days           vit      
25days    0.3830 
            Supple*Day             plac    25days           vit      
acute       0.4987 
            Supple*Day             plac    25days           vit      
pre          0.3494 
            Supple*Day             plac    acute            plac     
pre           0.0140 
            Supple*Day             plac    acute            vit      
25days      0.3919 
            Supple*Day             plac    acute            vit      
acute         0.5091 
            Supple*Day             plac    acute            vit      
pre            0.3577 
            Supple*Day             plac    pre              vit      
25days       0.9691 
            Supple*Day             plac    pre              vit      
acute          0.8117 
            Supple*Day             plac    pre              vit      
pre             0.9790 
            Supple*Day             vit     25days           vit      
acute        0.2896 
            Supple*Day             vit     25days           vit      
pre       0.7271 
            Supple*Day             vit     acute            vit      
pre         0.1639 
 
 
Table B.2 Power Analysis for Sample Size 
Subjects Per Group (2 groups) Alpha Power 
12 0.10 0.74 
14 0.10 0.80 
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Figure B.2 SAS Code for Power Analysis 
 
Data SizeFix; 
*Base specification; 
a=2;dfS=1; 
b=3;dfT=2; 
ab=6;dfST=2; 
*Specifications for power loop; 
*Change aS, aT, aST level to 0.1 for type I=0.1. Change n; 
aS =.05; cS =.75; cSsq = cS**2; powS =0; endS =.70; r=2; 
aT =.05; cT =.75; cTsq = cT**2; powT =0; endT =.70; n=12; 
aST=.05; cST=.75; cSTsq=cST**2; powST=0; endST=.70; w=1; 
*Power loop; 
Do until (powS >= endS and powT >= endT and powST >= endST); 
 nObs = r*a*n*b*w; *Experiment size and error degrees of freedom; 
 dfE1 = dfS*(r-1) + r*a*(n-1); 
 dfE2 = dfT*(r-1) + dfT*dfE1 + r*a*n*b*(w-1); 
 nS = r*n*b*w; *nTildas for noncentrality parameters; 
 nT = r*a*n*w; 
 nST = r*n*w; 
 parmS = nS * cSsq /2; *Noncentrality parameters; 
 parmT = nT * cTsq /2; 
 parmST = nST *cSTsq /2; 
 fS = Finv(1-aS , dfS,  dfE1, 0); *Critical F values; 
 fT = Finv(1-aT , dfT,  dfE2, 0);  
 fST =Finv(1-aST, dfST, dfE2, 0); 
 powS = 1 - ProbF(fS, dfS, dfE1, parmS); *Power; 
 powT = 1 - ProbF(fT, dfT, dfE2, parmT); 
 powST = 1 - ProbF(fST, dfST, dfE2, parmST);  
 output; 
 r=r+1; *nTilda ratches; 
 *n=n+1; 
 *w=w+1; 
 End; 
 Proc Print; Var r n w dfE1 dfE2 powS powT powST nObs; 
 run; quit; 
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Appendix C: ANOVA Statistics Dissertation Study 
 
Table B.1 ANOVA table  
Source DF SS MS F Pr 
train 1 1765764.150 1765764.150 3.62 0.07 
supp 3 274571.469 91523.823 0.19 0.90 
train X supp 3 180431.321 60143.774 0.12 0.95 
error 32 15604409.30 487637.79   
total 39 17922768.64    
 
 
 
Table B.2 Bonferroni Pairwise Tests 
supp train supp train t-value Pr 
acute pla trained acute pla untrained0.48 0.6369
acute pla trained acute vit trained _0.96 0.3425
acute pla trained acute vit untrained0.35 0.7316
acute pla trained chronic trained _0.69 0.4945
acute pla trained chronic untrained0.28 0.7837
acute pla trained chronic trained _0.78 0.4395
acute pla trained chronic untrained0.53 0.6023
acute pla untrained acute vit trained _1.34 0.1902
acute pla untrained acute vit untrained_0.12 0.9059
acute pla untrained chronic trained _1.09 0.2818
acute pla untrained chronic untrained_0.18 0.8564
acute pla untrained chronic trained _1.18 0.248
acute pla untrained chronic untrained0.05 0.9641
acute vit trained acute vit untrained1.21 0.236
acute vit trained chronic trained 0.27 0.7871
acute vit trained chronic untrained1.14 0.2633
acute vit trained chronic trained 0.18 0.8577
acute vit trained chronic untrained1.39 0.1747
acute vit untrained chronic trained _0.96 0.3422
acute vit untrained chronic untrained_0.06 0.95
acute vit untrained chronic trained _1.05 0.3033
acute vit untrained chronic untrained0.16 0.8703
chronic trained chronic untrained0.89 0.3775
chronic trained chronic trained _0.09 0.9276
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chronic trained chronic untrained1.14 0.2609
chronic untrained chronic trained _0.98 0.336
chronic untrained chronic untrained0.23 0.8212
chronic trained chronic untrained1.23 0.229 
 
 
Figure B.1 SAS Code for Power Analysis 
 
/*Dissertation power analysis*/ 
data Power; 
FSUPPSTATUS=Finv(0.90, 3, 32,0); PSUPPSTATUS=1-
ProbF(FSUPPSTATUS,3,32,-2.43); 
FTRAINING=Finv(0.90, 1, 32, 0); PTRAINING=1-
ProbF(FTRAINING,1,32,2.62); 
FSUbyTRAIN=Finv(0.90, 3, 32,0); PSUbyTRAIN=1-
ProbF(FSUbyTRAIN,3,32,-2.64); 
proc print NoObs; 
run; 
quit; 
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Appendix D: Consent Form 
 
1.   Study Title:     
The effect of an antioxidant supplementation protocol upon muscular fatigue in trained and untrained 
subjects during repetitive arm curl exercise 
2.   Performance Sites:    
  Exercise testing will be done in room B13 of the Gym Aromory 
3.   Contacts:    
  Dr. Arnold Nelson    Ivan K Guillory 
  112 Long Field House, LSU   1476 Lake Calais Ct, Apt D 
  Baton Rouge, LA 70803   Baton Rouge, LA 70808 
  phone (work) (225) 578-2036 (7 am - 4 pm) phone (225) 757-9527 
  Home (225) 766-4621 (5 pm - 10 pm) 
  e-mail: anelso@lsu.edu    e-mail: iguillo@attglobal.net     
4.   Purpose of the Study:   
  The purpose of this study is to determine whether or not supplementing with vitamins A, 
C, and E will attenuate the fatigue seen performing a prescribed arm curl exercise protocol. 
5.   Subjects:       
  A.  Inclusion Criteria    
 Forty healthy subjects are needed. Both males and females are invited to participate. 
Participation is voluntary. Two types of subjects are needed, trained and untrained group. Untrained is 
defined as individuals who do not currently participate in strength building exercise. Trained subjects 
are those currently undergoing a strength building program with a frequency of no less than three days 
per week. All potential participants must complete the Physical Activity Readiness Questionnaire 
(PAR-Q) before inclusion into the study.  Only those individuals who answer “no” to all questions will 
be used as research participants. 
  B.  Exclusion Criteria    
 Any person on any type of medication, or currently supplementing with any antioxidant 
vitamins. Also anyone who knows that they are hypersensitive to vitamins A, C, or E. 
  C.  Maximum number of subjects: (including controls)  
   40 
6. Study Procedures:     
Supplementation Protocol 
 Before the supplementation protocol can begin each subject will compile a seven day food diary 
to assess antioxidant vitamin status. Each diary will be assessed for RDA levels of the selected 
vitamins, and to what extent that those levels have been met or exceeded.  Subjects will ingest an 
antioxidant tablet containing 25,000 international units of beta carotene, 400 international units of 
vitamin E, and 500 milligrams of vitamin C. or a placebo (sugar pill).  Subjects will supplement on an 
antioxidant vitamin tablet containing the aforementioned substances, for a total of fifteen days. After a 
thirty day washout period, they  will be ingesting a placebo for fifteen days.  Beta carotene is an 
antioxidant that is a precursor to vitamin A, often called pro-vitamin A. Vitamin E is used in the body 
to protect cell membranes from oxidation. Vitamin C, among its other functions, acts as an antioxidant 
and helps to regenerate vitamin E. The dosages that we are using are considered safe and are even 
within the guidelines established by the United States Olympic Sports Medicine Committee (Table 1) 
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Table 1. 
Nutrient Supplement Range 
Beta Carotene    5,000 – 33,000 IU 
Vitamin C    250 – 1,000 mg 
Vitamin E    100 – 400 IU 
 
Invasive Procedures (OPTIONAL) 
 To have a better understanding of the residual amount in the blood of the above vitamins, blood 
will be taken at two different time during the study.  The first blood sample will be taken at the end of 
the washout period and before the second supplementation period.  The second blood sample will be 
taken at the end of the study.  All blood draws will be performed at the cmedical clinic of the 
Pennington Biomedical Research Center.  A total of 5 ml of blood will be taken by a certified 
phlebotomist at each of the two times mentioned above.  The blood samples will be analyzed for 
vitamin concentration by the clinical chemistry specialists at the Pennington Biomedical Research 
Center. PLEASE NOTE THAT THESE BLOOD DRAWS ARE OPTIONAL.  ANYONE WHO DOES 
NOT DESIRE TO HAVE THEIR BLOOD SAMPLED WILL NOT BE ASKED TO DO SO NOR BE 
ASKED TO TERMINATE THEIR PARTICIPATION IN THE STUDY. 
 
Testing Protocol 
 The testing procedure will consist of an initial assessment using a Biodex dynamometer., and 
subsequent tests at day one and day fifteen of each supplementation period. The exercise protocol will 
consist of six sets of arm curl exercises, using the left arm, with a one minute rest between each set. 
Twenty repetitions will constitute one full set. The speed of movement will be set at 60 degrees per 
second for flexion and, 400 degrees per second for extension (this speed will allow subjects to relax on 
the eccentric phase). The subjects will be instructed to give all out effort for each set. Subsequently 
total work (force multiplied by distance) for each set will be measured by the dynamometer in order to 
give a measure of the rate of fatigue. 
 
Time line for Experiment 
Days 1-7 Subjects record diet for seven days. At the end 
of the recording period, subjects will have the 
initial assessment on the dynamometer. 
Day 14 and 15 Subjects begin the supplementation period. 
On the second day, they will again be 
assessed on the dynamometer. 
Day 28 Subjects continue supplementation, and on the 
fifteenth day are assessed on the dynamometer 
Day 29 - 58 Subjects undergo washout period 
Day 58 Volunteers will report to the Pennington 
Clinic for a blood draw. 
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Day 59 and 60 Subjects begin the second supplementation 
period. On the second day, they will again be 
assessed on the dynamometer. 
Day 73 On the last day of supplementation, subjects 
will again be assessed on the dynamometer 
Day 74 Volunteers will report to the Pennington 
Clinic for a blood draw. 
7. Benefits:  
 Subjects may benefit from the study from learning their status for these selected antioxidants 
after completing the food diary. They may also discover a beneficial effect upon muscular fatigue 
individually, after supplementing with the antioxidants. Also, general knowledge about the practice of 
supplementing with vitamins and their affect upon muscle fatigue will be learned and added to the 
current body of literature on the subject. 
8. Risks/Discomforts:   
 There are small inherent risks involved with taking place in this study. It’s possible that the 
subject could strain a muscle, experience light headedness, or nausea as they will be required to give 
maximal effort. There is no report risk for the supplementing these vitamins at the proposed dosage.  At 
this time, however, the researcher will read to you the manufacturer’s warning label  
 Additional risks may be encountered by those individuals who volunteer for the two blood 
samples.  A person having  a blood sample runs the risk of pain at the site of the blood draw, bruising at 
the same site, and the development of blood clots (hematoma) at the blood draw site.  The chances of 
either bruising and developing blood clots are greatly reduced if the person follows the instructions of 
the phlebotomist. 
9. Measures taken to reduce risk  
 All subjects will do a warm-up routine before exercising, this will help reduce the risk in the 
trained subjects. Warm-up will reduce exercise risk in untrained individuals very little. The only way to 
them to reduce the risks of the exercise is not to perform the exercise. 
 To reduce the risks associated with a blood drawn, only trained certified personnel in the 
employment of the Pennington Center will be allowed to take the blood samples. 
10. Right to Refuse:   
 ll volunteers may terminate their participation at anytime and without warning. The individual 
just needs to stop the activity and leave the weight room. No attempt will be made by the research 
personnel to stop the volunteer.  In fact, the research personal will do all in their power to help the 
volunteer leave at any time. 
11. Privacy:    
 The results of this study will be tabulated in an anonymous manner.  This means that the 
researchers will be unable to give you your results, as they will not be able to identify yours from the 
rest.      
12. Financial Information:    
 This project will not effect the participants finances in either a positive or a negative manner. 
13. Withdrawal:    
 Withdrawal form the study can occur at anytime without any fear of punitive action. 
14. Removal:    
 If the researcher has trouble scheduling the volunteer to come to the test, or if it is discovered 
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that the subject is not taken the pills in the prescribed manner, that volunteer will be dropped from the 
list of volunteers.  The volunteer has the right to change their minds about participation at anytime 
before or during the study. 
    ---------------------------------------------------------------------------------- 
 
 
Part 5: Signatures: 
 
1. ‘The study has been discussed with me and all my questions have been answered. I may direct 
additional questions regarding study specifics to the investigators. If I have questions about 
subjects' rights or other concerns, I can contact Robert C. Mathews, Chairman, LSU 
Institutional Review Board, (225)578_8692. I agree to participate in the study described above 
and acknowledge the researchers’ obligation to   provide me with a copy of this consent form if 
signed by me.’ 
 
 Subject Signature ___________      Date ________________________________ 
 
2. ‘The study subject has indicated to me that he/she is unable to read. I certify that I have 
read this consent form to the subject and explained that by completing the signature line above, 
the subject has agreed to participate.’ 
 
 Signature of Reader _______________   Date ________________________________ 
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Appendix E:Power and Statistical Significance 
When conducting statistical tests to describe the characteristics of a group of data there 
are certain distinct measures that come in to play. Those measures include, probability (alpha and 
beta), effect size, and power. 
Probability is defined as the chance that a certain event will occur. An example used 
frequently is in the case of flipping a coin. One would expect that if a coin is tossed 50 times it 
would come up heads 25 times and tails 25 times or 50% (0.50). This may or may not occur, 
however if this test were repeated a number of times you would expect the frequency of scores to 
be closely huddled around 50% (Thomas and Nelson, 2001). In statistics probability statements 
are used to describe confidence in the findings of the research. In research, probability is used to 
protect against making two types of error - Type I and Type II. Type I error occurs when the null 
hypothesis is rejected although it is true. Type II error is to fail to reject the null hypothesis when 
it is false.  
The probability statistic used to guard against a Type I error is called alpha. The 
statement used to describe the confidence placed in statistical findings is called a probability 
statement (Thomas and Nelson, 2001; Freund and Wilson, 1997). A typical probability statement 
may appear as p<0.01, meaning the difference detected would be expected less than 1% of the 
time as a result of chance. Within the science community the alpha level is almost always set at 
either 0.01 or 0.05. As mentioned previously this is done to protect against a Type I error. For 
example, in an experiment in which a supplement is given, Type I error protects against 
detecting a difference when the supplementation really had no effect. The higher the alpha level 
the more opportunity that is given to show any difference but, conversely the chance of Type I 
error increases. There is no official reasoning as to why 0.05 and 0.01 have been accepted by the 
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scientific community as the “gold standard” for alpha level. The decision comes down to which 
type of error is more acceptable to the researcher, Type I or Type II. In a study in which a drug is 
being tested, but has never shown to be harmful, it might be acceptable to set alpha at 0.10 to 
give that drug every opportunity to have an effect. In a paper by Franks and Huck (1987) it is 
posed that there are indeed instances when a higher significance level may be warranted. Sample 
size can be determined via a formula that takes into account, among other things, alpha level. 
However, in many instances in exercise and physical activity research, there are times when 
there is only a limited sample available. In addition, there are factors that are beyond control 
such as costs of the experiment, subject dropouts and / or availability, and incomplete data 
(Franks and Huck, 1987). In this case setting alpha at 0.10 or another value may be worth the 
added risk of Type I error when weighted against the consequence of committing a Type II error. 
Finally, in the example of the drug testing, in an exploratory study it may actually be more costly 
to experience a Type II error, that is, the drug actually has an effect, but the researcher accepts 
the null hypothesis of no effect. 
Beta is the test statistic used to specify the probability of making a Type II error. Again, 
the Type II error is a failure to reject the null hypothesis when it is false. If sample size stays the 
same beta will grow smaller as alpha is increased (Freund and Wilson, 1997). Conversely, power 
is the probability of rejecting the null hypothesis when it is false (Thomas and Nelson, 2001). 
The subject of power will be covered later in this paper. 
Effect size (ES), or meaningfulness of differences, has been defined as “the magnitude of 
the real effect to be detected” (Thomas, Lochbaum, Landers, and He, 1997). Simply put it is the 
meaningfulness of difference between two means (Thomas and Nelson, 2001). It is calculated as: 
(Me - Mc)/Sc 
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This calculation is the mean of the experimental group minus the mean of the control group with 
the difference divided by the standard deviation of the control group (Thomas, Lochbaum, 
Landers, and He, 1997). If there is no control group, a pooled standard deviation between the two 
group means should be used (Thomas and Nelson, 2001; Hedges and Olkin, 1985). Guidelines 
for behavioral research were suggested by Cohen (1969) and within those guidelines he 
suggested an ES of 0.2 as small; 0.5 as moderate; and 0.8 as large differences. Thomas, Salazar, 
and Landers (1991) posed the idea that all authors of research should report ES in their analysis. 
One reason for this is the chance that small differences may be declared significant because of a 
combination of a large sample and small variance, or a large variance and small sample size. In a 
paper by Cohen (1990) it is argued that the main purpose of research should be to measure effect 
size rather than p values. The logic behind this is that a single study based upon a decision at the 
p<0.05 level is not likely to have an impact upon theory, but that reporting effect size allows 
there to be a standard of comparison between past, present, and future research. Clearly this 
would help to guide research on the selected topic for the future. As will be discussed later, ES, 
alpha level, and sample size are instrumental in helping to determine power for a given study. If 
the sample size is low, as is the case many times in physical education research, a higher than 
normal alpha level, or large ES, or both may have to be adopted to maintain a certain desired 
level of power (Thomas and Nelson, 2001) 
Statistical power has been described as “the probability of not making a Type II error” 
(Norton and Strube, 2001). In other words, it is the probability of making a correct 
determination. Consequently, if beta is representative of the probability of making a Type II 
error, then the probability of not making a Type II error is mathematically represented as 1 - 
beta. Therefore,        1 - beta may be labeled as the mathematical expression of power. The 
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greater the power, the higher the chance of detecting a real difference in the analysis. The four 
main components that affect power are alpha level, group means, sample size and variability 
among subjects (Norton and Strube, 2001). Alpha level affects power indirectly, through its 
influence upon Type I and Type II error. When alpha is increased, the chance of making a Type I 
error is increased, while at the same time the chance of making a Type II error is decreased 
because beta is decreased. A subsequent decrease in beta results in an increase in power, because 
of the mathematical relationship of beta and power (power = 1 - beta). Group means have an 
influence on power through their differences between the group means for the null hypothesis 
and experimental group means. Logic tells us that the larger the difference between group means, 
the easier the detection of any differences. In other words, power increases when the difference 
between the two means becomes larger. Subject variability may also have an effect on power. In 
a graphic comparison between two distribution of scores, one distribution curve may have the 
same mean of another distribution curve. However, one curve may be wider than the other 
because of greater variability among the scores within its distribution. If these two curves 
overlap and one represents the distribution of the null hypothesis and the other the research 
hypothesis, the greater the overlap in the scores between the two distributions, the larger the beta 
and therefore a subsequent decrease in power (Norton, and Strube, 2001). Finally, the sample 
size may also influence power. Basically, as sample size is increased power is increased. 
Increasing sample size reduces the variability of the sample group means (Thomas and Nelson, 
2001; Norton and Strube, 2001). 
Via the use of a power analysis it is possible to determine the number of subjects or 
observations necessary when planning a study. Using ES, alpha level and power it is possible to 
calculate a value for sample size. As stated previously, ES may be determined by a previous pilot 
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study, or it may be determined from the means of a number of related studies (Thomas et al, 
1997). It is suggested that the ratio of alpha level to beta level should be 1 to 4 (Thomas and 
Nelson, 2001). For example, if an alpha of 0.05 was selected then beta should be set at 0.20 and, 
likewise when alpha is set at 0.10 beta should be set at 0.40 ( power = 0.60). Again, the 
researcher must determine what type of error is most important to avoid within the planned 
study. Upon obtaining the ES, alpha level and effect size, the sample size is determined via effect 
size curves (Thomas and Nelson, 2001; Thomas et al, 1997), using simple formulas (Cohen and 
Cohen, 1983), or relying upon statistical software such as SAS or SPSS. As noted earlier, sample 
size has a large influence upon power. For example, for an ES = 0.5 and an alpha of 0.05, a 
sample size of 10 results in a power = 0.20 and a sample size of 20 would result in power = 0.30 
(Thomas and Nelson, 2001). 
Power analysis may also be used after the completion of a study. After the study is 
completed, a power analysis can determine if the level of power is adequate to justify any kind of 
conclusion (Norton and Strube, 2001). For instance, after the power analysis is finished if the 
power level is determined to be lower than the desired level, then a decision must be made by the 
researcher to either not accept the result due to inadequate power or risk the increased chance of 
a Type II error. This kind of problem may occur if there are a significant amount of subjects that 
drop out or discontinue participation in the study. Again, power analysis is usually determined 
using statistical software such as SPSS or SAS. 
It is well known that statistical significance is representative of a test of the difference 
between experimental groups (Thomas et al, 1997). Either a difference between group means is 
significant at the specified alpha level or it is not significant. However, there is a distinction 
between the significance of the differences and the meaningfulness of the differences. By 
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definition meaningfulness is “the importance or practical significance of an effect or 
relationship” (Thomas and Nelson, 2001). It is plausible then, for a study to have outcomes that 
are not statistically significant but, because of the effect size(s), may have a meaningful outcome 
when compared to effect sizes within the existing literature (Thomas et al, 1997; Norton and 
Strube, 2001; Thomas and Nelson, 2001). Effect size makes it possible to compare results across 
many different studies, that address a similar question, because of the way it standardizes the 
effect magnitude to a value that can be compared, although scaling properties of the 
measurements of each study are different (Norton and Strube, 2001). So, regardless of the 
statistical significance at a given alpha level for a given study, studies still can be compared and 
may still contribute to the existing knowledge in regards to the particular question being 
addressed. 
As an example of determining sample size, we could consider the improvement of world 
class sprinters attempting to improve their time in the 400-meter run. If we wanted to see if a 
certain supplement, in this case creatine phosphate, improved 400-meter sprint times we would 
first conduct a pilot study in which one group (experimental group) of sprinters ingested the 
creatine supplement for a given amount of time, and the other group (control group) ingested a 
placebo. There are 10 athletes in each group. Each sprinter would be timed in the 400 meters 
before the supplementation began, and at the end of the supplementation period. Afterwards, 
their improvement in hundredths of seconds would be recorded. In world class sprinters we 
would not expect a large improvement. Improvements in that event are sometimes measured in 
tenths or hundredths of seconds. However, that small improvement may well be the difference 
between an Olympic gold medal and fourth place. So, following a pilot study we calculated the 
mean of the difference in pre- and post-supplementation times for the five athletes in the 
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experimental group and the control group. The experimental group received five grams of 
creatine per day for thirty days and the control group received a placebo for the same amount of 
time. Afterwards, their improvements were recorded. The mean improvement for the 
experimental group was 0.1 seconds and the control group was 0.05 seconds. The standard 
deviation of the control group is equal to 0.03. So, with this information we can calculate a 
sample size needed for a larger study. We use the same formula mentioned earlier to first find the 
effect size: 
(Me - Mc)/Sc 
(0.10 - 0.05)/0.03 = 1.6 
With an ES = 1.6, we will assume a desired power as 0.8 and an alpha level of 0.05. Using 
Sigma Stat statistical software package to calculate a sample size for a one way ANOVA, we 
would find that we need two groups of seven subjects to detect a meaningful difference between 
the two groups, supplemented and placebo. 
Now that we have the minimum sample size we can collect the data from the main study. 
Since we need a minimum of 7 subjects per group we recruit twenty subjects. Then we set up a 
similar protocol to the pilot study. Ten subjects will ingest the creatine for thirty days and the 
other ten will ingest the placebo. Four hundred meter sprint times are tested before and 
immediately after supplementation. In the experimental group the mean of the differences 
between pre and post supplementation is equal to 0.33, and for the placebo group 0.06. 
Following a one way ANOVA it is found that there is a significant difference between the 
experimental group and the placebo group such that p<0.001. Following the test, we determine 
the power to be equal to 1.0 taking into account the difference of the means (0.27) and a p=.001. 
So, following this test we would conclude that supplementation with creatine is beneficial to 
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world class 400-meter sprinters in reducing their 400-meter sprint times. However, if the case 
had been that the p=0.07 and the power were .75 then the researcher would have to make the 
decision as to which error is most acceptable. With an alpha level at 0.07 the chances of rejecting 
the null hypothesis when it is true is 7 times out of 100. Conversely, the power is 0.75 which is 
not 0.8, but very close. In a study such as the aforementioned, the researcher is using a 
supplement (creatine) that has not been shown to be harmful with only 30 days of 
supplementation. So, the decision may be made to reject the null (of no benefit) to give the 
supplement every opportunity to work. This may not be a bad decision with the power being 
0.75. A power at that level would indicate that there is a 25% chance of making a Type II error. 
But, again, as the null is that there is no benefit from taking creatine, making a Type II error 
would not be harmful to the participants and may be worth the risk to the investigator. This 
would have to be the options weighed before a decision is made whether to accept or reject the 
null hypothesis. 
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Appendix F: Obtaining and Motivating Subjects 
When conducting a study that entails subjects having to take a drug / supplement and 
then to perform an exercise protocol at specified intervals throughout a calendar year, there are 
inherently some issues that rise up that affect subject compliance and motivation. 
One concern that has been apparent is the subjects initial apprehension towards the 
supplement. Since, most lay people are not educated about nutrition or experimental research 
some questions arise as to the harmful or possible side effects of the supplement. At the 
beginning of any study involving the supplementation of a nutritional aid, the researcher should 
explain in detail the nature of the action that the supplement has within the body. This should be 
done through a group question and answer period and in a detailed written description of the 
supplement and its action / side effects. 
Obtaining subjects for physical activity research can be difficult if there is no incentive 
for subjects to participate. For example, Cohen, Chelland, Ball, and LeMura (2002) used 
monetary reward to subjects participating in a physical activity study involving riding a cycle 
ergometer. They found that the monetary rewards motivated the subjects to ride for a longer time 
on the cycles than when no money was awarded. For many researchers the awarding of a 
monetary sum to all subjects is just not financially feasible. However, if they were to make it into 
a contest or lottery situation in which the subject with the best effort, or best attendance, won a 
reward, this would serve to be a motivating factor because it would appeal to the subjects 
competitiveness. Another example of a reward system would involve soliciting college students 
to participate, whereupon the researcher negotiates rewards for their participation via the college 
/ university or individual professors, preferably in courses related to physical activity.  
It may be difficult to keep subjects motivated if a study is long or involved. There are 
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also factors such as boredom, activity preferences, and even group cohesion that may affect 
subjects lack of compliance during a study. Perhaps having periodical meetings of the subjects 
would help to motivate individuals. These meetings could serve as question and answer, as well 
as motivational periods. When the subjects see that they are a part of a larger group, this may 
help to motivate them to continue in the study (Spink and Carron, 1992). Encouragement and 
accountability to the group may serve as a motivating factor for individuals who feel isolated and 
are not sure that their participation makes any kind of difference. If subjects do not enjoy the 
mode of exercise being used in a study, then the likelihood of them staying motivated and 
participating in the study is diminished. When individuals are enjoying an activity they get 
positive feedback from that participation (ACSM, 1993, pp. 447). However, if they do not then 
they experience the opposite feelings (Stutts, 2001). 
If time permits researchers may be able to use advance advertisement to recruit 
volunteers. Yancy et al (2001) used what is referred to as passive and active recruitment. Passive 
recruitment involved placing ads in the local paper or radio station (public service 
announcements), and also social networking. They also posted flyers at community sites and 
organizations such as churches, grocery stores, and neighborhood centers. This strategy could 
easily be adopted to a university setting by utilizing the school newspaper, radio station, student 
health center, recreational center, or personal friendships / relationships. They also used a 
method called active recruitment in which potential subjects were contacted directly. The 
methods used included mass mailings, presentations at selected churches, meetings of 
community organizations, and community health fairs. Again, in the case of recruiting from a 
university population these methods may be adapted to that particular community. Investigators 
could send out detailed letters to professors and leaders of student organizations to define what 
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the study is investigating, in hopes that these leaders will motivate their students or members to 
participate in the study. Likewise the investigators could make presentations at the meetings of 
said student organizations to introduce the students to the type of work being performed and how 
the students can help, and possibly even benefit from participation. During these presentations 
they can appeal to the audience’s desire to help others, if the study has some medical or health 
ramifications. As most universities now have student health fairs during the school year, these 
are prime locations to introduce the work that the group is doing, and to request volunteers for 
the upcoming study. To ensure the target population are being admitted to the study, researchers 
could also use a screening questionnaire. In the case of a study needing subjects from a certain 
age range, and / or fitness level, a questionnaire could be tailored to include domains such as 
smoking status, disease status, age range, etc. (Yancy et al, 2001). These methods have been 
used by many researchers to transcend the obstacles to recruiting subjects for physical activity 
research. 
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Appendix G: Journal Article 
Introduction 
The recent interest in antioxidants and free radicals has prompted an increase in the 
supplementation of these substances by many in the general public. Athletes believe that 
supplementing their diet with antioxidants helps to maintain their optimum fitness level. To this 
end vitamin manufacturers market antioxidants to athletes, professional and amateur alike, as an 
ergogenic aid counteracting the effect of oxidative stress during exercise (Urso and Clarkson, 
2003; Applegate, 1999; Juhn, 2003; American Dietetic Association [ADA], 2000). It is well 
accepted that exercise causes an increase in the production of free radicals and other reactive 
oxygen species (ROS) (Powers and Hamilton, 1999). Among these ROS are O2- (superoxide 
radical), H2O2 (hydrogen peroxide), and OH (hydroxy free radicals). A proliferation of these free 
radicals can cause a decrease in the function of affected cells and can result in a decreased ability 
of muscles to maintain work. Some may believe that the ingestion of antioxidants will help to 
stave off this proliferation of free radicals during exercise and thus provide a beneficial effect. 
The human body has adequate antioxidant defenses under normal physiological 
conditions. These defenses include enzymatic and nonenzymatic antioxidants within the interior 
and exterior of cells. The non-enzymatic include antioxidant vitamins, uric acid, glutathione, 
alpha lipoic acid, bilirubin, and ubiquinones (Powers and Hamilton, 1999). Enzymatic 
antioxidants are located mainly within the mitochondria and cytosol, and include superoxide 
dismutase, glutathione peroxidase, and catalase  
Vitamin E, vitamin C, and beta-carotene are three antioxidants that have garnered the 
most attention from those who wish to supplement their diets with exogenous nutrients. Vitamin 
E works to protect cell membranes by breaking the chain reactions that attack the lipid portions 
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of those membranes. Vitamin C is an antioxidant that works in conjunction with vitamin E and is 
located in the cytosol of cells. It helps to regenerate vitamin E that has been used to fight the 
lipid peroxidation occurring within cell membranes. Beta Carotene is a form of vitamin A called 
pro-vitamin A. It can be converted into vitamin A as needed by the body, and much of it is 
located between the lipid bilayers of cell membranes. In this position, it also acts as an 
antioxidant protecting cell membranes. 
During strenuous exercise, there is an increase in oxygen uptake by working muscles. As 
work intensifies, oxygen uptake increases. This increase in oxygen uptake results in an increase 
in ROS that may result in the fatiguing of working muscles (Powers and Hamilton, 1999; Davies, 
Quintanilha, Brooks, and Packer, 1982). There is evidence that suggests supplementing the diet 
with antioxidant nutrients may help to stave off the effects of an increase in ROS (Novelli, 
Bracciotti, and Falsini, 1990; LeBlanc, 1998; Lang, Gohil, and Packer, 1986; Samanta and 
Biswas, 1985; Brown et al, 1997; Allesio et al, 1997 ). However, most studies have investigated 
the effect of these antioxidants upon continuous endurance exercise, and have not used an 
intermittent work protocol, nor the three antioxidants in combination, being utilized here. 
In this study we have investigated the effect that an acute and a chronic supplementation 
regimen, with an antioxidant mixture of beta-carotene, vitamin C, and vitamin E, has upon work 
capacity during an intermittent work protocol in trained and untrained subjects. Additionally, we 
will observe if there is any significant interaction between the trained and untrained subjects 
work values from the acute placebo phase through the chronic vitamin phase. 
 
Methods 
Subjects. Thirty-six male and female volunteers were recruited, aged 19-34 years, who, 
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after completing an informed consent form, were deemed healthy and on no medications. 
Subjects were classified as either trained (n=24) or untrained (n=12). Trained were those who 
engage in strength training on a regular basis (at least one day per week) for a period of at least 
one year. Untrained were those who do not participate in any strength training. All subjects were 
required to be nonsmokers and to not be taking any vitamin supplements at the time of the study. 
Dietary Assessment. A subgroup of ten subjects completed a 3-day food diary prior to 
supplementation to assess current intake for the antioxidants being ingested. The information 
therein was analyzed using the software, Food Processor for Windows (version 7.30) by ESHA 
Research. 
Experimental Design. Subjects ingested either one antioxidant capsule containing (25,000 
IU of beta-carotene, 400 IU of vitamin E, and 500 mg of vitamin C), or a disguised placebo, per 
day for a period of 25 days. The capsules were administered in a double blind fashion so as to 
remove bias from the investigation. The antioxidant capsules are produced by Vitamin World, 
Inc. and, are manufactured to the standards of the United States Pharmacopeia / National 
Formulary requirements. 
The testing procedure consisted of an initial practice session using the Biodex 
dynamometer (one week prior to supplementation), and subsequent tests at day one and day 
twenty-eight of each supplementation period. Each subject was tested within a 12 hour range of 
the time of the original test, for each of the subsequent tests. For example, if the original test was 
at noon, then the tests at one day and twenty-eight days would be between six a.m. and six p.m. 
on those days.  The exercise protocol consisted of five sets of arm curl exercises, using the non-
dominant arm, with a 1 minute rest between each set. Twenty repetitions constituted one full set. 
The speed of movement was set at 60 degrees per second for flexion and, a maximum of 400 
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degrees per second for extension (this speed allowed subjects to relax on the eccentric phase). 
The subjects were instructed to give all out effort for each set. Subsequently, total work (force 
multiplied by distance) for each set was measured by the dynamometer in order to give a 
measure of the rate of fatigue. The sum of the total work of the last two sets was used in 
determining fatigue. 
Statistical Analysis. Following data collection all results will be analyzed and compared 
for significance. A two-way (treatment X day) ANOVA with an alpha level of p<0.10, was used 
to compare within and between group differences. 
Results 
Dietary Assessment.  Subjects completed the 3-day food diary to assess current intake for 
the supplemented antioxidants. The information therein was analyzed using the software, Food 
Processor for Windows (version 7.30) by ESHA Research, as described earlier. The results for 
each subject are listed in table 1. The means for each antioxidant are listed for each subject for 
the three day period. This allowed estimation of the extent to which the RDA for the selected 
antioxidants are being met or exceeded, in the regular diet. Mean group values for beta-carotene, 
vitamin C, and vitamin E respectively, were equal to 1791.415 mcg (St err = 738.819), 175.645 
mg (St err = 94.007), and 6.678 mg (St err = 1.752). 
 
 
 
Table 1 Antioxidant Vitamin Measures From Food Diary Data 
Subjects Beta-car. (mcg) Vitamin C (mg) Vitamin E (mg) 
1 811.12 98.42 2.68 
2 498.62 87.89 5.30 
3 3122.46 1017.19 14.56 
4 1388.48 63.19 4.21 
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5 330.18 99.37 3.98 
6 9.38 31.12 4.96 
7 574.32 107.25 8.50 
8 223.93 102.29 1.58 
9 7494.26 31.42 2.72 
10 3461.40 118.31 18.29 
 
Work Measures. Following the intermittent work protocol, work measures for each 
subject at each supplementation period were recorded (Table 2). The protocol was conducted on 
the Biodex dynamometer in the kinesiology lab at Louisiana State University. Mean values for 
each phase are reported in Table 3. 
Table 2. Work Measures for Each Subject 
 
status 
 
acute plac 
 chronic plac acute vit chronic vit 
untrained   326.1 396.7 
untrained   884.3 1034.3 
untrained   675.2 807.7 
untrained   789.4 676.1 
untrained   460.9 599.9 
untrained   1194.7 1116.1 
untrained   806.1 1219.6 
untrained   796.9 719.6 
trained 622.4 690.2   
trained 699.2 1039.6   
trained 1213.1 1628.4   
trained 1801.5 2080.4   
trained 1545.6 1501.2   
trained 980.4 993.5   
trained 1322.5 1413.3   
trained 1234.1 1028.9   
trained   1493.9 1212.9 
trained   1154.8 1021.1 
trained   1486.9 1316.3 
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trained   1939.1 1688.1 
trained   1753.4 1740.1 
trained   1879.2 1972.1 
trained   754.7 583.6 
trained   1168.4 1022.2 
trained   1288.4 1072.7 
trained   915.8 679.4 
trained   923.5 969.4 
trained   1186.1 1321.7 
trained   688.4 731.2 
trained   1490.1 1414.9 
trained   1484.9 2228.6 
trained   1217.4 1058.4 
untrained 673.8 754.1   
untrained 1385.8 1314.7   
untrained 678 530.7   
untrained 209.6 411.5   
 
Table 3 Work Mean Values 
Status Supp. Phase Mean Work  
trained acute placebo 1178.29 
trained chronic placebo 1321.14 
trained acute vitamin 1142.12 
trained chronic vitamin 1072.59 
untrained acute placebo 823.60 
untrained chronic placebo 827.70 
untrained acute vitamin 1048.93 
untrained chronic vitamin 1195.53 
 
A two way ANOVA was used to detect any differences in the data. Although upon viewing the 
data graphically (Figures 1 and 2) there appears to be an influence upon the untrained subjects  
supplementing with the antioxidant, the data show otherwise. For the main effects 
supplementation status, and training, there were p values of 0.88 and 0.09 respectively. For the 
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interaction of supplementation status and training, p value was equal to 0.25. There was a small 
effect size of 0.26 for the effect of training. Power for supplement phase, training, and their 
interaction was <0.10, 0.29, and <0.10 respectively. 
Discussion 
Dietary Assessment. Vitamins C and E, and beta-carotene intakes were estimated using 
3-day food diaries. Each subject was given a diary to completely record everything that was 
eaten during  a three day period. As invasive measures of these two of the nutrients were not 
investigated,  it was determined that recording daily intake of these nutrients would provide the 
best estimate of tissue levels for this particular group. Assessment of the subjects’ status in 
regards to the antioxidants studied, was necessary to ensure that there were none of them starting 
from a point of deficiency, prior to the start of the experiment.  
Currently there is no RDA for beta-carotene in humans. However, the RDA for vitamin A 
is 0.8 - 1.0 retinol equivalents (RE) (Groff et al, 1995). Beta-carotene is a precursor to vitamin A, 
and is often called pro-vitamin A.. The body cleaves stored beta carotene as needed to maintain 
serum vitamin A levels within the body.   
There appears to be no serious side effects when ingesting beta-carotene in excess of the 
RDA for vitamin A because it is not converted to vitamin A until the body needs it. 
Following diet analysis for each subject, the software displayed information for each 
vitamin and mineral with an RDA and also other nutrients, such as beta-carotene, that do not 
currently have an RDA. The Food Processor for Windows software reported total vitamin A / 
provitamin A in the diet. It also gave beta-carotene content as a separate measure from total 
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Figure 1 Trained Subjects Work Graph 
 
 
 
 
 
 
 
 
 
Figure 2. Untrained Subjects Work Graph 
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vitamin A content. Our subjects mean intake for beta-carotene during the three days of listing 
food intake was 1791.415 mcg (Std = 2336.35). Six micrograms of beta-carotene is equal to one 
RE. Again, this measure was just a part of the total vitamin A intake, but it does illustrate the 
extent to which the subjects were meeting the RDA for vitamin A. On average the subjects 
ingested 298.57 RE per day for the three day period. This far exceeds the RDA for vitamin A and 
ensures, barring any malabsorptive disorders (pancreatic, liver, or gall bladder diseases), that the 
subject pool was not vitamin A deficient prior to the supplementation regimen (Beta-carotene 
ingestion for each subject is listed in table 1). 
The RDA for vitamin E is 8 mg and 10 mg tocopherol equivalents (TE) per day, for 
women and men respectively. The normal intake for vitamin E in American diets is 4 mg TE to 
22 mg TE/day for individuals not supplementing their diet with exogenous vitamin E (Di Mascio 
et al, 1991). Again, vitamin E requirements increase as the intake of PUFA increases or 
decreases. Because of this dependency upon PUFA content, determining a precise requirement 
for vitamin E has been difficult. However, because most foods high in PUFA are also high in 
vitamin E, there is not much fear of deficiency. In fact, vitamin E deficiency in humans is very 
rare. As in the case with beta-carotene, deficiency in adults is only seen in those suffering from 
malabsorption diseases, especially those that affect the absorption of fats. 
The diet analysis determined that the mean intake for vitamin E for each subject for the 
three day period was 6.678 mg TE/day (Std dev=5.54). This is just below the RDA for vitamin E 
but is well within the normal intake for those consuming a typical American diet (Di Mascio et 
al, 1991). This also falls between the range stated by Guthrie and Picciano (1995), between 5 and 
20 mg TE/day, that would be considered safe depending upon PUFA intake. Considering the 
rarity of vitamin E deficiency, and the fact that our subjects intake of vitamin E falls between the 
 117
range for normal intake, it is highly unlikely that these subjects were vitamin E deficient before 
beginning the supplementation regimen. 
The RDA for vitamin C is 60 mg/day for adult men and women. This amount was chosen 
based upon the amount required to maintain a body pool of 1500 mg (the amount of vitamin C 
that can be held within the body without excretion via the kidneys). The subjects’ food diaries 
showed that the mean intake for each subject per day was 175.645 mg of vitamin C per day (Std 
dev=297.28). This number exceeds the amount in the RDA, but is far below the amount 
indicated in vitamin C toxicity (Alhadeff et al, 1984). Again, it is highly unlikely that subjects 
were vitamin C deficient before beginning the supplementation protocol.   
Work Measures. Subjects were supplemented with a placebo or the antioxidant vitamin 
mixture (beta-carotene, vitamin E, and vitamin C) to see if a chronic dose would cause an affect 
upon the work capacity during the arm curl protocol, from acute to chronic supplementation 
phase. As was noted, there is scant research investigating the affect of an acute (one day) versus 
chronic (25 days) ingestion of either of the three antioxidant nutrients upon muscular fatigue 
during the arm curl protocol prescribed in this study. In addition, no studies using the 
intermittent arm curl protocol were found throughout the literature. Although, there were 
differences seen graphically as described earlier, there were no significant differences seen in the 
interaction of supplement status and training state (p=0.25). There was a significant effect for 
training state (p=0.09) which was not unexpected, since the trained subjects were continuing in 
their strength training program during the time of supplementation and work testing. 
With the significance level determined from statistical analysis, we observed that the 
interaction did not reach significance (p=0.25). However, we cannot make this determination 
with any confidence because of the power being <0.10 . The power is the probability of making a 
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correct decision (rejecting the null hypothesis when it is false). So, under these conditions it is 
not possible to make a decision and be confident in it.  
Although there is not a significant interaction, there does appear to be a trend towards an 
interaction graphically (figures 1 and 2). We know that the analysis for this investigation resulted 
in a low power. However, power can be increased by increasing the sample size. It may be 
possible that with an increase in subjects, the interaction between supplemental status and 
training may become significant. In the graph we notice a fairly even mean scores from acute 
placebo to chronic vitamin states in the trained individuals. These subjects may have such an 
adaptation to increased ROS via their training activites, that they may not notice any influence of 
supplementated antioxidants upon work. Conversely the untrained subjects appear to benefit 
from the vitamin supplementation  graphically (figure 2), from the acute supplementation 
compared to the chronic supplementation. Finally, it is believed that for the future a larger 
sample size should be utilized and may possibly show a significant interaction between the 
trained and untrained subjects. 
Power, in this instance, appears to have been heavily influenced by the variability of the 
results. The variance for the supplement status, training phase, and their interaction is 44524.25 
(Std dev.=211.01), 614972.03 (Std dev.=784.20), and 283840.37 (Std dev.=532.77). These are 
large values and show that if the scores were represented by a curve on a scale, the curve would 
be extremely wide. The narrower the curve the more chance there is of detecting a difference 
between the curve representing the null hypothesis and the curve representing the research 
hypothesis.  
Additionally, the concept fatigue is multifaceted and encompasses physiological as well 
as psychological factors (Astrand, 1986). It may be possible that the influence of the antioxidant 
 119
supplement may not be enough to make a noticeable impact upon work measures. 
In summary, there were no determinations that could be made from the work measure 
values because of the low power. However, we were able to evaluate the dietary status of each 
subject for the prescribed antioxidants via the food diary. For the future, researchers may want to 
consider a longer supplementation period or larger sample size to be able to detect significant 
differences between the trained and untrained groups using the same protocol. Additionally, a 
study design entailing a crossover may allow for less variability since each subject would have 
the opportunity to fall under both treatments. 
 
 
Note: References listed in reference list; None of the subjects are the same in this study (i.e. there 
are no repeats because this data is the combined data of pilot and dissertation work) 
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